Skip to main content Accessibility help
The Biology of Schwann Cells
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 5
  • Export citation
  • Recommend to librarian
  • Buy the print book

Book description

Schwann cells are a diverse group of cells formed from neural crest cells. They are essential components of the peripheral nerves of both vertebrate and invertebrate nervous systems. The diversity of Schwann cell subsets and function is seen in those Schwann cells that form myelin - that uniquely specialised part of the plasma membrane that spirals around axonal lengths to myelinate the peripheral nerves. The Biology of Schwann Cells concentrates on the cells of mammals and in particular humans. It covers the distinction between compact and non-compact myelin in depth, along with the perisynaptic cells which form the partnership between nerve terminals and muscle fibre. Developmental aspects are discussed alongside differentiation, and the genetics of the cells in health and disease. With chapters from world-renowned experts, this book is aimed at postgraduates and researchers in neuroscience and neurology and anyone involved in the study of peripheral nerves.

Refine List

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Send to Kindle
  • Send to Dropbox
  • Send to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.


Adam, A. M., Atkinson, P. F., Hall, S. M., Hughes, R. A. and Taylor, W. A. (1989). Chronic experimental allergic neuritis in Lewis rats. Neuropathol Appl Neurobiol 15, 249–64.
Adams, D., Festenstein, H., Gibson, J. al. (1979). HLA antigens in chronic relapsing idiopathic inflammatory polyneuropathy. J Neurol Neurosurg Psychiatry 42, 184–6.
Agresti, C., D'Urso, D. and Levi, G. (1996). Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-alpha on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci 8, 1106–16.
Ahmed, M. R., Basha, S. H., Gopinath, D., Muthusamy, R. and Jayakumar, R. (2005). Initial upregulation of growth factors and inflammatory mediators during nerve regeneration in the presence of cell adhesive peptide-incorporated collagen tubes. J Peripher Nerv Syst 10, 17–30.
Ahn, M., Lee, Y., Moon, al. (2004). Upregulation of osteopontin in Schwann cells of the sciatic nerves of Lewis rats with experimental autoimmune neuritis. Neurosci Lett 372, 137–41.
Ainsworth, P. J., Bolton, C. F., Murphy, B. C., Stuart, J. A. and Hahn, A. F. (1998). Genotype/phenotype correlation in affected individuals of a family with a deletion of the entire coding sequence of the connexin 32 gene. Hum Genet 103, 242–4.
Akassoglou, K., Probert, L., Kontogeorgos, G. and Kollias, G. (1997). Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 158, 438–45.
Akassoglou, K., Bauer, J., Kassiotis, al. (1998). Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol 153, 801–13.
Akassoglou, K., Bauer, J., Kassiotis, al. (1999). Transgenic models of TNF induced demyelination. Adv Exp Med Biol 468, 245–59.
Akassoglou, K., Kombrinck, K. W., Degen, J. L. and Strickland, S. (2000). Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury. J Cell Biol 149, 1157–66.
Akassoglou, K., Yu, W. M., Akpinar, P. and Strickland, S. (2002). Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation. Neuron 33, 861–75.
Al-Din, A. N., Anderson, M., Bickerstaff, E. R. and Harvey, I. (1982). Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain 105 (Pt 3), 481–95.
Albrecht, D. E. and Froehner, S. C. (2004). DRP2 and Dp116 Form Spatially Distinct Dystrophin-like Complexes in the Schwann Cells of Peripheral Nerves. American Society for Cell Biology, Washington DC, Abstract.
Allen, D., Giannopoulos, K., Gray, al. (2005). Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 10, 174–80.
Allen, N. J., Barres, B. A. (2005). Signaling between glia and neurons: focus on synaptic plasticity. Curr Opin Neurobiol 15, 542–8.
Altevogt, B. M., Kleopa, K. A., Postma, F. R., Scherer, S. S. and Paul, D. L. (2002). Cx29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems. J Neurosci 22, 6458–70.
Alvarez-Buylla, A. and Lim, D. A. (2004). For the long run: maintaining germinal niches in the adult brain. Neuron 41, 683–6.
American Academy of Neurology (1991). Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 41, 617–18.
Ammoumi, A. A., Pertschuk, L., Daras, M. and Rosen, A. D. (1980). Guillain–Barré syndrome; results of direct immunofluorescent study. NY State J Med 80, 1434–5.
Andorfer, B., Kieseier, B. C., Mathey, al. (2001). Expression and distribution of transcription factor NF-kappaB and inhibitor IkappaB in the inflamed peripheral nervous system. J Neuroimmunol 116, 226–32.
Andrews, T., Zhang, P. and Bhat, N. R. (1998). TNFalpha potentiates IFNgamma-induced cell death in oligodendrocyte progenitors. J Neurosci Res 54, 574–83.
Anzini, P., Neuberg, D. H., Schachner, al. (1997). Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32. J Neurosci 17, 4545–51.
Aoki, E., Semba, R. and Kashiwamata, S. (1991). Evidence for the presence of L-arginine in the glial components of the peripheral nervous system. Brain Res 559, 159–62.
Apostolski, S., Sadiq, S. A., Hays, al. (1994). Identification of Gal(beta 1–3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J Neurosci Res 38, 134–41.
Araque, A., Parpura, V., Sanzgiri, R. P. and Haydon, P. G. (1999). Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 22, 208–15.
Archelos, J. J., Roggenbuck, K., Schneider-Schaulies, J., Linington, C., Toyka, K. V. and Hartung, H. P. (1993). Production and characterization of monoclonal antibodies to the extracellular domain of P0. J Neurosci Res 35, 46–53.
Arenander, A. and De Vellis, J. (1999). Development of the nervous system. Siegel, G. (Ed.) Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. Raven Press, New York, pp. 573–606.
Argall, K. G., Armati, P. J., Pollard, J. D. and Bonner, J. (1992a). Interactions between CD4+ T-cells and rat Schwann cells in vitro. 2. Cytotoxic effects of P2-specific CD4+ T-cell lines on Lewis rat Schwann cells. J Neuroimmunol 40, 19–29.
Argall, K. G., Armati, P. J., Pollard, J. D., Watson, E. and Bonner, J. (1992b). Interactions between CD4+ T-cells and rat Schwann cells in vitro. 1. Antigen presentation by Lewis rat Schwann cells to P2-specific CD4+ T-cell lines. J Neuroimmunol 40, 1–18.
Armati, P. J. and Pollard, J. D. (1987). Cytotoxic response of serum from patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Acta Neurol Scand 76, 24–7.
Armati, P. J. and Pollard, J. D. (1996). Immunology of the Schwann cell. Baillieres Clin Neurol 5, 47–64.
Armati, P. J., Pollard, J. D. and Gatenby, P. (1990). Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle Nerve 13, 106–16.
Arroyo, E. J. and Scherer, S. S. (2000). On the molecular architecture of myelinated fibers. Histochem Cell Biol 113, 1–18.
Arroyo, E. J., Sirkowski, E. E., Chitale, R. and Scherer, S. S. (2004). Acute demyelination disrupts the molecular organization of PNS nodes. J Comp Neurol 479, 424–34.
Arteaga, M. F., Gutierrez, R., Avila, J., Mobasheri, A., Diaz-Flores, L. and Martin-Vasallo, P. (2004). Regeneration influences expression of the Na+, K+-atpase subunit isoforms in the rat peripheral nervous system. Neuroscience 129, 691–702.
Asbury, A. K. and Cornblath, D. R. (1990). Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol 27 Suppl, S21–4.
Asbury, A. K., Arnason, B. G. and Adams, R. D. (1969). The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) 48, 173–215.
Asbury, A. K., Arnason, B. G. W., Karp, H. R. and McFarlin, D. F. (1978). Criteria for diagnosis of Guillain–Barré syndrome. Ann Neurol 3, 565–6.
Astrow, S. H., Son, Y. J. and Thompson, W. J. (1994). Differential neural regulation of a neuromuscular junction-associated antigen in muscle fibers and Schwann cells. J Neurobiol 25, 937–52.
Astrow, S. H., Tyner, T. R., Nguyen, M. T. and Ko, C. P. (1997). A Schwann cell matrix component of neuromuscular junctions and peripheral nerves. J Neurocytol 26, 63–75.
Astrow, S. H., Qiang, H. and Ko, C. P. (1998). Perisynaptic Schwann cells at neuromuscular junctions revealed by a novel monoclonal antibody. J Neurocytol 27, 667–81.
Asundi, V. K., Erdman, R., Stahl, R. C. and Carey, D. J. (2003). Matrix metalloproteinase-dependent shedding of syndecan-3, a transmembrane heparan sulfate proteoglycan, in Schwann cells. J Neurosci Res 73, 593–602.
Atanasoski, S., Notterpek, L., Lee, H. al. (2004). The protooncogene Ski controls Schwann cell proliferation and myelination. Neuron 43, 499–511.
Augustien, G. J., Burns, M. E., DeBello, W. al. (1999). Proteins involved in synaptic vesicle trafficking. J Physiol 520, 33–41.
Auld, D. S. and Robitaille, R. (2003a). Glial cells and neurotransmission: an inclusive view of synaptic function. Neuron 40, 389–400.
Auld, D. S. and Robitaille, R. (2003b). Perisynaptic Schwann cells at the neuromuscular junction: nerve- and activity-dependent contributions to synaptic efficacy, plasticity, and reinnervation. Neuroscientist 9, 144–57.
Auld, D. S., Colomar, A., Belair, E. al. (2003). Modulation of neurotransmission by reciprocal synapse–glial interactions at the neuromuscular junction. J Neurocytol 32, 1003–15.
Awasaki, T. and Ito, K. (2004). Engulfing action of glial cells is required for programmed axon pruning during Drosophila metamorphosis. Curr Biol 14, 668–77.
Awatramani, R., Shumas, S., Kamholz, J. and Scherer, S. S. (2002). TGFbeta1 modulates the phenotype of Schwann cells at the transcriptional level. Mol Cell Neurosci 19, 307–19.
Bachelin, C., Lachapelle, F., Girard, al. (2005). Efficient myelin repair in the macaque spinal cord by autologous grafts of Schwann cells. Brain 128, 540–9.
Baggiolini, M. (2001). Chemokines in pathology and medicine. J Intern Med 250, 91–104.
Bai, Y., Ianokova, E., Pu, al. (in press). R69C mutation in myelin protein zero causes early onset CMT1B with demyelination, dysmyelination and axonal loss. Arch Neurol.
Balarezo, F. S., Muller, R. C., Weiss, R. al. (2003). Soft tissue perineuriomas in children: report of three cases and review of the literature corrected. Pediatr Dev Pathol 6, 137–41.
Balice-Gordon, R. J., Bone, L. J. and Scherer, S. S. (1998). Functional gap junctions in the Schwann cell myelin sheath. J Cell Biol 142, 1095–104.
Ballesteros, J. A., Abrams, C. K., Oh, S., Verselis, V. K., Weinstein, H. and Bargiello, T. A. (1999). The role of a conserved proline residue in mediating conformational changes associated with voltage gating of Cx32 gap junctions. Biophy J 76, 2887–98.
Bao, J., Wolpowitz, D., Role, L. W. and Talmage, D. A. (2003). Back signaling by the Nrg-1 intracellular domain. J Cell Biol 161, 1133–41.
Barohn, R. J., Kissel, J. T., Warmolts, J. R. and Mendell, J. R. (1989). Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 46, 878–84.
Baron Van Evercooren, A., Kleiman, H. K., Seppa, J., Rentier, B. and Dubois-Dalcq, M. (1982). Fibronectin promotes rat Schwann cell growth and motility. J Cell Biol 93, 211–16.
Baxter, R. V., Ben Othmane, K., Rochelle, J. al. (2001). Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot–Marie–Tooth disease type 4A/8q21. Nat Genet 30, 21–2.
Be'eri, H., Reichert, F., Saada, A. and Rotshenker, S. (1998). The cytokine network of wallerian degeneration: IL-10 and GM-CSF. Eur J Neurosci 10, 2707–13.
Beams, H. W. and Evans, T. C. (1953). Electron micrographs of motor end-plates. Proc Soc Exp Biol Med 82, 344–6.
Bellone, E., Di Maria, E., Soriani, al. (1999). A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot–Marie–Tooth type 1 disease. Hum Mutat 14, 353–4.
Belmadani, A., Tran, P. B., Ren, D., Assimacopoulos, S., Grove, E. A. and Miller, R. J. (2005). The chemokine stromal cell-derived factor-1 regulates the migration of sensory neuron progenitors. J Neurosci 25, 3995–4003.
Bennett, V. and Baines, A. J. (2001). Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol Rev 81, 1353–92.
Bennett, C. L., Shirk, A. J., Huynh, H. al. (2004). SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerve. Ann Neurol 55, 713–20.
Berciano, J., Garcia, A., Calleja, J. and Combarros, O. (2000). Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot–Marie–Tooth disease 1A duplication. Neuromuscul Disord 10, 419–24.
Bergoffen, J., Scherer, S. S., Wang, al. (1993). Connexin mutations in X-linked Charcot–Marie–Tooth disease. Science 262, 2039–42.
Bergsteinsdottir, K., Kingston, A., Mirsky, R. and Jessen, K. R. (1991). Rat Schwann cells produce interleukin-1. J Neuroimmunol 34, 15–23.
Bergsteinsdottir, K., Kingston, A. and Jessen, K. R. (1992). Rat Schwann cells can be induced to express major histocompatibility complex class II molecules in vivo. J Neurocytol 21, 382–90.
Bermingham, J. R., Scherer, S. S., O'Connell, al. (1996). Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. Genes & Development 10, 1751–62.
Bermingham, J. R. Jr., Shearin, H., Pennington, al. (2006). The claw paw mutation reveals a role for Lgi4 in peripheral nerve development. Nat Neurosci 9, 76–84.
Berthold, C. H., Fraher, J. P., King, R. H. M. and Rydmark, M. (2005). Microscopic anatomy of the peripheral nervous system. Dyck, P. J., Thomas, P. K. (Eds.) Peripheral Neuropathy, 4th Edn, Elsevier Saunders, Philadelphia, PA, pp. 35–92.
Bigbee, J. W., Yoshino, J. E. and DeVries, G. H. (1987). Morphological and proliferative responses of cultured Schwann cells following rapid phagocytosis of a myelin-enriched fraction. J Neurocytol 16, 487–96.
Bigotte, L., Arvidson, B. and Olsson, Y. (1982). Cytofluorescence localization of adriamycin in the nervous system. II. Distribution of the drug in the somatic and autonomic peripheral nervous systems of normal adult mice after intravenous injection. Acta Neuropathol (Berl) 57, 130–6.
Birks, R., Huxley, H. E. and Katz, B. (1960a). The fine structure of the neuromuscular junction of the frog. J Physiol 150, 134–44.
Birks, R., Katz, B. and Miledi, R. (1960b). Physiological and structural changes at the amphibian myoneural junction, in the course of nerve degeneration. J Physiol 150, 145–68.
Bishop, D. L., Misgeld, T., Walsh, M. K., Gan, W. B. and Lichtman, J. W. (2004). Axon branch removal at developing synapses by axosome shedding. Neuron 44, 651–61.
Bitgood, M. J. and McMahon, A. P. (1995). Hedgehog and Bmp genes are coexpressed at many diverse sites of cell–cell interaction in the mouse embryo. Develop Biol 172, 126–38.
Bixby, S., Kruger, G. M., Mosher, J. T., Joseph, N. M. and Morrison, S. J. (2002). Cell-intrinsic differences between stem cells from different regions of the peripheral nervous system regulate the generation of neural diversity. Neuron 35, 643–56.
Bjartmar, C., Wujek, J. R. and Trapp, B. D. (2003). Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206, 165–71.
Blakemore, W. F. (2005). The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes. Neuropathol Appl Neurobiol 31, 1–10.
Blanchard, A. D., Sinanan, A., Parmantier, al. (1996). Oct-6 (SCIP/Tst-1) is expressed in Schwann cell precursors, embryonic Schwann cells, and postnatal myelinating Schwann cells: comparison with Oct-1, Krox-20, and Pax-3. J Neurosci Res 46, 630–40.
Boeke, J. (1949). The sympathetic endformation, its synaptology, the interstitial cells, the periterminal network, and its bearing on the neurone theory. Acta Anatomica 8, 18–61.
Boerkoel, C. F., Takashima, H., Stankiewicz, al. (2001). Periaxin mutations cause recessive Dejerine–Sottas neuropathy. Am J Hum Genet 68, 325–33.
Boiko, T., Rasband, M. N., Levinson, S. al. (2001). Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron 30, 91–104.
Bolin, L. M., Verity, A. N., Silver, J. E., Shooter, E. M. and Abrams, J. S. (1995). Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 64, 850–8.
Bolino, A., Muglia, M., Conforti, F. L. (2000). Charcot–Marie–Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25, 17–19.
Bonetti, B., Valdo, P., Stegagno, al. (2000). Tumor necrosis factor alpha and human Schwann cells: signalling and phenotype modulation without cell death. J Neuropathol Exp Neurol 59, 74–84.
Bonnon, C., Goutebroze, L., Denisenko Nehrbass, N., Girault, J. A. and Faivre Sarrailh, C. (2003). The paranodal complex of F3/Contactin and Caspr/Paranodin traffics to the cell surface via a non-conventional pathway. J Biol Chem 278, 48339–47.
Bouchard, C., Lacroix, C., Plante, al. (1999). Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 52, 498–503.
Bourde, O., Kiefer, R., Toyka, K. V. and Hartung, H. P. (1996). Quantification of interleukin-6 mRNA in wallerian degeneration by competitive reverse transcription polymerase chain reaction. J Neuroimmunol 69, 135–40.
Bourque, M. J. and Robitaille, R. (1998). Endogenous peptidergic modulation of perisynaptic Schwann cells at the frog neuromuscular junction. J Physiol 512 (Pt 1), 197–209.
Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W. and Taylor, J. M. (1985). Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76, 1501–13.
Bradley, W. G. and Jenkison, M. (1973). Abnormalities of peripheral nerves in murine muscular dystrophy. J Neurol Sci 18, 227–47.
Bradley, W. G., Jaros, E. and Jenkison, M. (1977). The nodes of Ranvier in the nerves of mice with muscular dystrophy. J Neuropathol Exp Neurol 36, 797–806.
Brady, S. T., Witt, A. S., Kirkpatrick, L. al. (1999). Formation of compact myelin is required for maturation of the axonal cytoskeleton. J Neurosci 19, 7278–88.
Braun, N., Sevigny, J., Robson, S. C., Hammer, K., Hanani, M. and Zimmermann, H. (2004). Association of the ecto-ATPase NTPDase2 with glial cells of the peripheral nervous system. Glia 45, 124–32.
Braunewell, K. H., Martini, R., LeBaron, al. (1995). Up-regulation of a chondroitin sulphate epitope during regeneration of mouse sciatic nerve: evidence that the immunoreactive molecules are related to the chondroitin sulphate proteoglycans decorin and versican. Eur J Neurosci 7, 792–804.
Bray, G. M., Perkins, S., Peterson, A. C. and Aguayo, A. J. (1977). Schwann cell multiplication deficit in nerve roots of newborn dystrophic mice. A radioautographic and ultrastructural study. J Neurol Sci 32, 203–12.
Brechenmacher, C., Vital, C., Deminiere, al. (1987). Guillain–Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients. Clin Neuropathol 6, 19–24.
Brennan, A., Dean, C. H., Zhang, A. L., Cass, D. T., Mirsky, R. and Jessen, K. R. (2000). Endothelins control the timing of Schwann cell generation in vitro and in vivo. Develop Biol 227, 545–57.
Brett, F. M., Costigan, D., Farrell, M. al. (1998). Merosin-deficient congenital muscular dystrophy and cortical dysplasia. Eur J Paediatr Neurol 2, 77–82.
Britsch, S., Li, L., Kirchhoff, al. (1998). The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. Genes & Development 12, 1825–36.
Britsch, S., Goerich, D. E., Riethmacher, al. (2001). The transcription factor Sox10 is a key regulator of peripheral glial development. Genes & Development 15, 66–78.
Brown, M. C., Holland, R. L. and Hopkins, W. G. (1981). Motor nerve sprouting. Ann Rev Neurosci 4, 17–42.
Bruck, W. (1997). The role of macrophages in Wallerian degeneration. Brain Pathol 7, 741–52.
Bruzzone, R. and Ressot, C. (1997). Connexins, gap junctions and cell–cell signalling in the nervous system. Eur J Neurosci 9, 1–6.
Bruzzone, R., White, T. W., Scherer, S. S., Fischbeck, K. H. and Paul, D. L. (1994). Null mutations of connexin32 in patients with X-linked Charcot–Marie–Tooth disease. Neuron 13, 1253–60.
Bruzzone, R., White, T. W. and Paul, D. L. (1996). Connections with connexins: the molecular basis of direct intercellular signaling. Eur J Biochem 238, 1–27.
Bult, C., Kibbe, W. A., Snoddy, al. (2004). A genome end-game: understanding gene function in the nervous system. Nat Neurosci 7, 484–5.
Bunge, M. B. (1993a). Schwann cell regulation of extracellular matrix biosynthesis and assembly. Dyck, P. J., Thomas, P. K., Griffin, J., Low, P. A., Poduslo, J. F. (Eds.) Peripheral Neuropathy, 3rd Edn, W. B. Saunders, Philadelphia, pp. 299–316.
Bunge, R. P. (1993b). Expanding roles for the Schwann cell: ensheathment, myelination, trophism and regeneration. Current Opin Neurobiol 3, 805–9.
Bunge, R. P. (1994). The role of the Schwann cell in trophic support and regeneration. J Neurol 242, S19–S21.
Bunge, M. W. P. and Wood, P. (2006). Transplantation of Schwann cells and olfactory ensheathing cells to promote regeneration in the CNS. Selzer, al. (Eds.) Textbook of Neural Repair and Rehabilitation. Cambridge University Press, Cambridge. pp. 513–31.
Bunge, R. P. and Bunge, M. B. (1983). Interrelationship between Schwann cell function and extracellular matrix production. Trends Neurosci499–505.
Byers, T. J., Lidov, H. G. and Kunkel, L. M. (1993). An alternative dystrophin transcript specific to peripheral nerve. Nat Genet 4, 77–81.
Caccamo, D. V., Ho, K. L. and Garcia, J. H. (1992). Cauda equina tumor with ependymal and paraganglionic differentiation. Hum Pathol 23, 835–38.
Cajal, S. R., DeFelipe, J. and Jones, E. G. (1991). Cajal's Degeneration and Regeneration of the Nervous System. Oxford University Press, Oxford.
Calabresi, P. A., Fields, N. S., Maloni, H. al. (1998). Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS. Neurology 51, 289–92.
Cambier, J. C., Littman, D. R. and Weiss, A. (2001). Antigen presentation to T lymphocytes. Janeway, J. (Ed.) Immunobiology. Garland Publishing, New York.
Cameron-Curry, P. (1995). Glial lineage of the peripheral nervous system. C R Seances Soc Biol Fil 189, 253–61.
Cameron-Curry, P., Dulac, C. and Douarin, N. M. (1993). Negative regulation of Schwann cell myelin protein gene expression by the dorsal root ganglionic microenvironment. Eur J Neurosci 5, 594–604.
Cammer, W. and Tansey, F. A. (1987). Immunocytochemical localization of carbonic anhydrase in myelinated fibers in peripheral nerves of rat and mouse. J Histochem Cytochem 35, 865–70.
Campana, W. M. and Myers, R. R. (2003). Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury. Eur J Neurosci 18, 1497–506.
Campana, W. M., Myers, R. R. and Rearden, A. (2003). Identification of PINCH in Schwann cells and DRG neurons: shuttling and signaling after nerve injury. Glia 41, 213–23.
Cao, G. and Ko, C. P. (2001). Schwann cell-conditioned medium modulates synaptic activities at Xenopus neuromuscular junctions in vitro. Society for Neuroscience Abstracts, 711, 12.
Carey, D. J. (1997). Syndecans: multifunctional cell-surface co-receptors. Biochem J 327 (Part 1), 1–16.
Carey, D. J., Todd, M. S. and Rafferty, C. M. (1986). Schwann cell myelination: induction by exogenous basement membrane-like extracellular matrix. J Cell Biol 102, 2254–63.
Carey, D. J., Crumbling, D. M., Stahl, R. C. and Evans, D. M. (1990). Association of cell surface heparan sulfate proteoglycans of Schwann cells with extracellular matrix proteins. J Biol Chem 265, 20627–33.
Carey, D. J., Evans, D. M., Stahl, R. al. (1992). Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan. J Cell Biol 117, 191–201.
Carey, D. J., Stahl, R. C., Asundi, V. K. and Tucker, B. (1993). Processing and subcellular distribution of the Schwann cell lipid-anchored heparan sulfate proteoglycan and identification as glypican. Exp Cell Res 208, 10–18.
Carey, D. J., Stahl, R. C., Cizmeci-Smith, G. and Asundi, V. K. (1994). Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading. J Cell Biol 124, 161–70.
Castonguay, A. and Robitaille, R. (2001). Differential regulation of transmitter release by presynaptic and glial Ca2+ internal stores at the neuromuscular synapse. J Neurosci 21, 1911–22.
Castro, C., Gomez-Hernandez, J. M., Silander, K. and Barrio, L. C. (1999). Altered formation of hemichannels and gap junction channels caused by C-terminal connexin-32 mutations. J Neurosci 19, 3752–60.
Causey, G. (1960). The Cell of Schwann. E&S Livingstone Ltd, Edinburgh.
Cavaletti, G., Fabbrica, D., Minoia, C., Frattola, L. and Tredici, G. (1998). Carboplatin toxic effects on the peripheral nervous system of the rat. Ann Oncol 9, 443–7.
Ceuterick-de Groote, C., Jonghe, P., Timmerman, V. (2001). Infantile demyelinating neuropathy associated with a de novo point mutation on Ser72 in PMP22 and basal lamina onion bulbs in skin biopsy. Pathol Res Pract 197, 193–8.
Chalasani, S. H., Baribaud, F., Coughlan, C. al. (2003a). The chemokine stromal cell-derived factor-1 promotes the survival of embryonic retinal ganglion cells. J Neurosci 23, 4601–12.
Chalasani, S. H., Sabelko, K. A., Sunshine, M. J., Littman, D. R. and Raper, J. A. (2003b). A chemokine, SDF-1, reduces the effectiveness of multiple axonal repellents and is required for normal axon pathfinding. J Neurosci 23, 1360–71.
Chan, et al. (2006). The polarity protein Par-3 directly interacts with p75NTR to regulate myelination. Science 314, 832–6.
Chan, J. R., Cosgaya, J. M., Wu, Y. J. and Shooter, E. M. (2001). Neurotrophins are key mediators of the myelination program in the peripheral nervous system. Proc Nat Acad Sci USA 98, 14661–8.
Chan, J. R., Watkins, T. A., Cosgaya, J. al. (2004). NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 43, 183–91.
Chance, P. F., Alderson, M. K., Leppig, K. al. (1993). DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72, 143–51.
Chandross, K. J., Spray, D. C., Cohen, R. al. (1996). TNF alpha inhibits Schwann cell proliferation, connexin46 expression, and gap junctional communication. Mol Cell Neurosci 7, 479–500.
Chao, C. C. and Hu, S. (1994). Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev Neurosci 16, 172–9.
Charcot, JM. and Marie, P. (1886). Sure une forme particulaire d'atrophie musculaire progressive souvent familial debutant par les pieds et les jambes et atteingnant plus tard les mains. Rev Med(Paris) 6, 97–138.
Chen, C., Bharucha, V., Chen, al. (2002). Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel β2-subunits. Proc Nat Acad Sci USA 99, 17072–7.
Chen, C. L., Westenbroek, R. E., Xu, X. al. (2004). Mice lacking sodium channel beta 1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J Neurosci 24, 4030–42.
Chen, L. and Ko, C. P. (1994). Extension of synaptic extracellular matrix during nerve terminal sprouting in living frog neuromuscular junctions. J Neurosci 14, 796–808.
Chen, L. E., Seaber, A. V., Wong, G. H. and Urbaniak, J. R. (1996). Tumor necrosis factor promotes motor functional recovery in crushed peripheral nerve. Neurochem Int 29, 197–203.
Chen, L. L., Folsom, D. B. and Ko, C. P. (1991). The remodeling of synaptic extracellular matrix and its dynamic relationship with nerve terminals at living frog neuromuscular junctions. J Neurosci 11, 2920–30.
Chen, L. M., Bailey, D. and Fernandez-Valle, C. (2000). Association of beta 1 integrin with focal adhesion kinase and paxillin in differentiating Schwann cells. J Neurosci 20, 3776–84.
Chen, S., Rio, C., Ji, R. R., Dikkes, P., Coggeshall, R. E., Woolf, C. J. and Corfas, G. (2003). Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss. Nat Neurosci 6, 1186–93.
Chen, Z. L. and Strickland, S. (2003). Laminin gamma1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve. J Cell Biol 163, 889–99.
Cheng, H. L., Russell, J. W. and Feldman, E. L. (1999). IGF-I promotes peripheral nervous system myelination. Ann NY Acad Sci 883, 124–30.
Cheng, H. L., Steinway, M., Delaney, C. L., Franke, T. F. and Feldman, E. L. (2000). IGF-I promotes Schwann cell motility and survival via activation of Akt. Mol Cell Endocrinol 170, 211–15.
Chernousov, M. A., Rothblum, K., Tyler, W. A., Stahl, R. C. and Carey, D. J. (2000). Schwann cells synthesize type V collagen that contains a novel alpha 4 chain. Molecular cloning, biochemical characterization, and high affinity heparin binding of alpha 4(V) collagen. J Biol Chem 275, 28208–15.
Chernousov, M. A. and Carey, D. J. (2003). AlphaVbeta8 integrin is a Schwann cell receptor for fibrin. Exp Cell Res 291, 514–24.
Chernousov, M. A., Stahl, R. C. and Carey, D. J. (2001). Schwann cell type V collagen inhibits axonal outgrowth and promotes Schwann cell migration via distinct adhesive activities of the collagen and noncollagen domains. J Neurosci 21, 6125–35.
Chiba, A., Kusunoki, S., Shimizu, T. and Kanazawa, I. (1992). Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller–Fisher syndrome. Ann Neurol 31, 677–9.
Chiba, A., Matsumura, K., Yamada, al. (1997). Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J Biol Chem 272, 2156–62.
Chiu, S. Y., Schrager, P. and Ritchie, J. M. (1984). Neuronal-type Na+ and K+ channels in rabbit cultured Schwann cells. Nature 311, 156–7.
Chow, I. and Poo, M. M. (1985). Release of acetylcholine from embryonic neurons upon contact with muscle cell. J Neurosci 5, 1076–82.
Christopherson, K. S., Ullian, E. M., Stokes, C. al. (2005). Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120, 421–33.
Chun, S. J., Rasband, M. N., Sidman, R. L., Habib, A. A. and Vartanian, T. (2003). Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination. J Cell Biol 163, 397–408.
Cifuentes-Diaz, C., Velasco, E., Meunier, F. al. (1998). The peripheral nerve and the neuromuscular junction are affected in the tenascin-C-deficient mouse. Cell Mol Biol (Noisy-le-Grand) 44, 357–79.
Ciment, G. (1990). The melanocyte Schwann cell progenitor: a bipotent intermediate in the neural crest lineage. Comments Dev Neurobiol 1, 207–23.
Clegg, D. O., Wingerd, K. L., Hikita, S. T. and Tolhurst, E. C. (2003). Integrins in the development, function and dysfunction of the nervous system. Front Biosci 8, 723–50.
Colby, J., Nicholson, R., Dickson, K. al. (2000). PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells. Neurobiol Dis 7, 561–73.
Colognato, H., Winkelmann, D. A. and Yurchenco, P. D. (1999). Laminin polymerization induces a receptor-cytoskeleton network. J Cell Biol 145, 619–31.
Colomar, A. and Robitaille, R. (2004). Glial modulation of synaptic transmission at the neuromuscular junction. Glia 47, 284–9.
Constable, A. L., Armati, P. J., Toyka, K. V. and Hartung, H. P. (1994). Production of prostanoids by Lewis rat Schwann cells in vitro. Brain Res 635, 75–80.
Constable, A. L., Armati, P. J. and Hartung, H. P. (1999). DMSO induction of the leukotriene LTC4 by Lewis rat Schwann cells. J Neurol Sci 162, 120–6.
Constantin, G., Piccio, L., Bussini, al. (1999). Induction of adhesion molecules on human Schwann cells by proinflammatory cytokines, an immunofluorescence study. J Neurol Sci 170, 124–30.
Constantinescu, C. S., Hilliard, B., Lavi, E., Ventura, E., Venkatesh, V. and Rostami, A. (1996). Suppression of experimental autoimmune neuritis by phosphodiesterase inhibitor pentoxifylline. J Neurol Sci 143, 14–18.
Cook, D. N., Pisetsky, D. S. and Schwartz, D. A. (2004). Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5, 975–9.
Corbin, J. G., Kelly, D., Rath, E. M., Baerwald, K. D., Suzuki, K. and Popko, B. (1996). Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 7, 354–70.
Corfas, G., Velardez, M. O., Ko, C. P., Ratner, N. and Peles, E. (2004). Mechanisms and roles of axon–Schwann cell interactions. J Neurosci 24, 9250–60.
Court, F. A., Sherman, D. L., Pratt, al. (2004). Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 431, 191–5.
Couteaux, R. (1938). Sur l'origine de la sole des plaques motrices. C R Soc Biol 127, 218–21.
Couteaux, R. (1973). Motor end-plate structure. Bourne, G. H. (Ed.) The Structure and Function of Muscle, 2nd Edn. Academic Press, New York, pp. 483–530.
Coyle, A. J. and Gutierrez-Ramos, J. C. (2001). The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol 2, 203–9.
Crawford, K. and Armati, P. J. (1982). The development of human fetal dorsal root ganglia in vitro: the first 20 days. Neuropathol Appl Neurobiol 8, 477–88.
Cuesta, A., Pedrola, L., Sevilla, al. (2001). The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot–Marie–Tooth type 4A disease. Nat Genet 30, 22–5.
Culican, S. M., Nelson, C. C. and Lichtman, J. W. (1998). Axon withdrawal during synapse elimination at the neuromuscular junction is accompanied by disassembly of the postsynaptic specialization and withdrawal of Schwann cell processes. J Neurosci 18, 4953–65.
Cummings, J. F., Lahunta, A. and Mitchell, W. J. Jr. (1983). Ganglioradiculitis in the dog. A clinical, light- and electron-microscopic study. Acta Neuropathol (Berl) 60, 29–39.
Custer, A. W., Kazarinov-Noyes, K., Sakurai, al. (2003). The role of the ankyrin-binding protein NrCAM in node of Ranvier formation. J Neurosci 23, 10032–9.
D'Antonio, M., Drogitti, A., Feltri, M. al. (2006). TGF beta type II recepter signalling controls Schwann cell death and proliferation in developing nerves. J Neurosci 26, 8417–27.
D'Urso, D., Brophy, P. J., Staugaitis, S. al. (1990). Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction. Neuron 4, 449–60.
Dahl, G., Werner, R., Levine, E. and Rabadan-Diehl, C. (1992). Mutational analysis of gap junction formation. Biophys J 62, 172–80.
Dahle, C., Ekerfelt, C., Vrethem, M., Samuelsson, M. and Ernerudh, J. (1997). T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain–Barré syndrome. J Neurol Sci 153, 54–60.
Dalakas, M. C. and Engel, W. K. (1981). Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 9 Suppl, 134–45.
Daniloff, J. K., Crossin, K. L., Pincon-Raymond, M., Murawsky, M., Rieger, F. and Edelman, G. M. (1989). Expression of cytotactin in the normal and regenerating neuromuscular system. J Cell Biol 108, 625–35.
Darbas, A., Jaegle, M., Walbeehm, al. (2004). Cell autonomy of the mouse claw paw mutation. Develop Biol 272, 470–82.
Day, N. C., Wood, S. J., Ince, P. al. (1997). Differential localization of voltage-dependent calcium channel alpha1 subunits at the human and rat neuromuscular junction. J Neurosci 17, 6226–35.
Waegh, S. and Brady, S. T. (1990). Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions. J Neurosci 10, 1855–65.
Waegh, S. M., Lee, V. M. and Brady, S. T. (1992). Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68, 451–63.
Dedek, K., Kunath, B., Kananura, C., Reuner, U., Jentsch, T. and Steinlein, O. K. (2001). Myokymia and neonatal epilepsy caused by a mutation in the voltage sensory of the KCNQ2 K − channel. Proc Nat Acad Sci USA 98, 12272–7.
Delpech, A., Girard, N. and Delpech, B. (1982). Localization of hyaluronectin in the nervous system. Brain Res 245, 251–7.
Dennis, M. J. and Miledi, R. (1974). Electrically induced release of acetylcholine from denervated Schwann cells. J Physiol 237, 431–52.
Deodato, F., Sabatelli, M., Ricci, al. (2002). Hypermyelinating neuropathy, mental retardation and epilepsy in a case of merosin deficiency. Neuromuscul Dis 12, 329–98.
Desaki, J. and Uehara, Y. (1981). The overall morphology of neuromuscular junctions as revealed by scanning electron microscopy. J Neurocytol 10, 101–10.
Descarries, L. M., Cai, S., Robitaille, R., Josephson, E. M. and Morest, D. K. (1998). Localization and characterization of nitric oxide synthase at the frog neuromuscular junction. J Neurocytol 27, 829–40.
Deschenes, S. M., Walcott, J. L., Wexler, T. L., Scherer, S. S. and Fischbeck, K. H. (1997). Altered trafficking of mutant connexin32. J Neurosci 17, 9077–84.
Devaux, J. J. and Scherer, S. S. (2005). Altered ion channels in an animal model of Charcot–Marie–Tooth disease type IA. J Neurosci 25, 1470–80.
Devaux, J., Alcaraz, G., Grinspan, al. (2003). Kv3.1 is a novel component of CNS nodes. J Neurosci 23, 4509–18.
Devaux, J. J., Kleopas, A. K., Cooper, E. C. and Scherer, S. S. (2004). KCNQ2 is a nodal K+ channel. J Neurosci 24, 1236–44.
Di Muzio, A., Angelis, M. V., Di Fulvio, al. (2003). Dysmyelinating sensory-motor neuropathy in merosin-deficient congenital muscular dystrophy. Muscle Nerve 27, 500–6.
Dickens, P., Hill, P. and Bennett, M. R. (2003). Schwann cell dynamics with respect to newly formed motor-nerve terminal branches on mature (Bufo marinus) muscle fibers. J Neurocytol 32, 381–92.
Doetsch, F. (2003). The glial identity of neural stem cells. Nature Neurosci 6, 1127–34.
Donaghy, M., Gray, J. A., Squier, al. (1989). Recurrent Guillain–Barré syndrome after multiple exposures to cytomegalovirus. Am J Med 87, 339–41.
Dong, Z., Brennan, A., Liu, al. (1995). Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors. Neuron 15, 585–96.
Dong, Z., Sinanan, A., Parkinson, D., Parmantier, E., Mirsky, R. and Jessen, K. R. (1999). Schwann cell development in embryonic mouse nerves. J Neurosci Res 56, 334–48.
Dore-Duffy, P., Balabanov, R., Washington, R. and Swanborg, R. H. (1994). Transforming growth factor beta 1 inhibits cytokine-induced CNS endothelial cell activation. Mol Chem Neuropathol 22, 161–75.
Dowsing, B. J., Morrison, W. A., Nicola, N. A., Starkey, G. P., Bucci, T. and Kilpatrick, T. J. (1999). Leukemia inhibitory factor is an autocrine survival factor for Schwann cells. J Neurochem 73, 96–104.
Duggins, A. J., McLeod, J. G., Pollard, J. al. (1999). Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 122 (Part 7), 1383–90.
Dulac, C. and Douarin, N. M. (1991). Phenotypic plasticity of Schwann cells and enteric glial cells in response to the microenvironment. Proc Nat Acad Sci USA 88, 6358–62.
Dunaevsky, A. and Connor, E. A. (1995). Long-term maintenance of presynaptic function in the absence of target muscle fibers. J Neurosci 15, 6137–44.
Dunaevsky, A. and Connor, E. A. (1998). Stability of frog motor nerve terminals in the absence of target muscle fibers. Dev Biol 194, 61–71.
Dunaevsky, A. and Connor, E. A. (2000). F-actin is concentrated in nonrelease domains at frog neuromuscular junctions. J Neurosci 20, 6007–12.
Dupin, E., Baroffio, A., Dulac, C., Cameron-Curry, P. and Douarin, N. M. (1990). Schwann-cell differentiation in clonal cultures of the neural crest, as evidenced by the anti-Schwann cell myelin protein monoclonal antibody. Proc Nat Acad Sci USA 87, 1119–23.
Dupin, E., Glavieux, C., Vaigot, P. and Douarin, N. M. (2000). Endothelin 3 induces the reversion of melanocytes to glia through a neural crest-derived glial-melanocytic progenitor. Proc Nat Acad Sci USA 97, 7882–7.
Dupin, E., Real, C., Glavieux-Pardanaud, C., Vaigot, P. and Douarin, N. M. (2003). Reversal of developmental restrictions in neural crest lineages: transition from Schwann cells to glial-melanocytic precursors in vitro. Proc Nat Acad Sci USA 100, 5229–33.
Dyck, P. J. (1975). Inherited neuronal degeneration and atrophy affecting peripheral motor, sensory and autonomic neurons. Dyck, P. J. (Ed.) Peripheral Neuropathy, 1st Edn. W.B. Saunders, Philadelphia, p. 825.
Dyck, P. J. and Lambert, E. H. (1968a). Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 18, 603–18.
Dyck, P. J. and Lambert, E. H. (1968b). Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol 18, 619–25.
Dyck, P. J., Lais, A. C., Ohta, M., Bastron, J. A., Okazaki, H. and Groover, R. V. (1975). Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 50, 621–37.
Dytrych, L., Sherman, D. L., Gillespie, C. S. and Brophy, P. J. (1998). Two PDZ domain proteins encoded by the murine periaxin gene are the result of alternative intron retention and are differentially targeted in Schwann cells. J Biol Chem 273, 5794–800.
Eccleston, P. A. (1992). Regulation of Schwann cell proliferation: mechanisms involved in peripheral nerve development. Expe Cell Res 199, 1–9.
Eccleston, P. A., Jessen, K. R. and Mirsky, R. (1989). Transforming growth factor-beta and gamma-interferon have dual effects on growth of peripheral glia. J Neurosci Res 24, 524–30.
EFN and PNS Task Force (2005). European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 10, 220–8.
Eichberg, J. and Iyer, S. (1996). Phosphorylation of myelin protein: recent advances. Neurochem Res 21, 527–35.
Einheber, S., Milner, T. A., Giancotti, F. and Salzer, J. L. (1993). Axonal regulation of Schwann cell integrin expression suggests a role for alpha 6 beta 4 in myelination. J Cell Biol 123, 1223–6.
Einheber, S., Hannocks, M. J., Metz, C. N., Rifkin, D. B. and Salzer, J. L. (1995). Transforming growth factor-beta 1 regulates axon/Schwann cell interactions. J Cell Biol 129, 443–58.
Eldridge, C. F., Bunge, M. B., Bunge, R. P. and Wood, P. M. (1987). Differentiation of axon-related Schwann cells in vitro. I. Ascorbic acid regulates basal lamina assembly and myelin formation. J Cell Biol 105, 1023–34.
Eldridge, C. F., Bunge, M. B. and Bunge, R. P. (1989). Differentiation of axon-related Schwann cell in vitro: II. Control of myelin formation by basal lamina. J Neurosci 9, 625–38.
Elson, K., Ribeiro, R. M., Perelson, A. S., Simmons, A. and Speck, P. (2004). The life span of ganglionic glia in murine sensory ganglia estimated by uptake of bromodeoxyuridine. Exp Neurol 186, 99–103.
Empl, M., Renaud, S., Erne, al. (2001). TNF-alpha expression in painful and nonpainful neuropathies. Neurology 56, 1371–7.
Engel, A. G. (1994). The neuromuscular junction. Engel, A. G., Franzini-Armstrong, C. (Eds.) Myology. McGraw-Hill Professional, New York.
English, A. W. (2003). Cytokines, growth factors and sprouting at the neuromuscular junction. J Neurocytol 32, 943–60.
Erdman, R., Stahl, R. C., Rothblum, K., Chernousov, M. A. and Carey, D. J. (2002). Schwann cell adhesion to a novel heparan sulfate binding site in the N-terminal domain of alpha 4 type V collagen is mediated by syndecan-3. J Biol Chem 277, 7619–25.
Ersdal, C., Ulvund, M. J., Espenes, A., Benestad, S. L., Sarradin, P. and Landsverk, T. (2005). Mapping PrPSc propagation in experimental and natural scrapie in sheep with different PrP genotypes. Vet Pathol 42, 258–74.
Ervasti, J. M. and Campbell, K. P. (1993). A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122, 809–23.
Exley, A. R., Smith, N. and Winer, J. B. (1994). Tumour necrosis factor-alpha and other cytokines in Guillain–Barré syndrome. J Neurol Neurosurg Psych 57, 1118–20.
Eylar, E. H., Uyemura, K., Brostoff, S. W., Kitamura, K., Ishaque, A. and Greenfield, S. (1979). Proposed nomenclature for PNS myelin proteins. Neurochem Res 4, 289–93.
Fabry, Z., Topham, D. J., Fee, al. (1995). TGF-beta 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J Immunol 155, 325–32.
Falls, D. L. (2003). Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284, 14–30.
Fannon, A. M., Sherman, D. L., Ilyina-Gragerova, G., Brophy, P. J., Friedrich, V. L. Jr. and Colman, D. R. (1995). Novel E-cadherin-mediated adhesion in peripheral nerve: Schwann cell architecture is stabilized by autotypic adherens junctions. J Cell Biol 129, 189–202.
Feasby, T. E., Hahn, A. F. and Gilbert, J. J. (1982). Passive transfer studies in Guillain–Barré polyneuropathy. Neurology 32, 1159–67.
Feasby, T. E., Gilbert, J. J., Brown, W. al. (1986). An acute axonal form of Guillain–Barré polyneuropathy. Brain 109 (Part 6), 1115–26.
Feasby, T. E., Hahn, A. F., Brown, W. F., Bolton, C. F. and Gilbert, J. J. (1988). Two types of axonal degeneration in acute Guillain–Barré syndrome. J Neurol 235, S15.
Feder, N. (1971). Microperoxidase – an ultrastructural tracer of low molecular weight. J Cell Biol 51, 339–43.
Feltri, M. L. and Wrabetz, L. (2005). Laminins and their receptors in Schwann cells and hereditary neuropathies. J Peripher Nerv Syst 10, 128–43.
Feltri, M. L., Scherer, S. S., Nemni, al. (1994). β4 integrin expression in myelinating Schwann cells is polarized, developmentally regulated and axonally dependent. Development 120, 1287–1301.
Feltri, M. L., Arona, M., Scherer, S. S. and Wrabetz, L. (1997). Cloning and sequence of the cDNA encoding the beta 4 integrin subunit in rat peripheral nerve. Gene 186, 299–304.
Feltri, M. L., Graus, P. D., Previtali, S. al. (2002). Conditional disruption of beta 1 integrin in Schwann cells impedes interactions with axons. J Cell Biol 156, 199–209.
Feng, Z. and Ko, C. P. (2004). Transforming growth factor (TGF)-beta 1 mediates Schwann cell-induced synaptogenesis at the neuromuscular junction in vitro. Program No 385 18, Abstract Viewer/Itinerary Planner Washington, DC: Society for Neuroscience.
Feng, G., Mellor, R. H., Bernstein, al. (2000). Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28, 41–51.
Feng, Z., Koirala, S. and Ko, C. P. (2005). Synapse–glia interactions at the vertebrate neuromuscular junction. Neuroscientist 11, 503–13.
Fenzi, F., Benedetti, M. D., Moretto, G. and Rizzuto, N. (2001). Glial cell and macrophage reactions in rat spinal ganglion after peripheral nerve lesions: an immunocytochemical and morphometric study. Arch Ital Biol 139, 357–65.
Fernandez-Valle, C., Gwynn, L., Wood, P. M., Carbonetto, S. and Bunge, M. B. (1994). Anti-beta 1 integrin antibody inhibits Schwann cell myelination. J Neurobiol 25, 1207–26.
Fernandez-Valle, C., Tang, Y., Ricard, al. (2002). Paxillin binds Schwannomin and regulates its density-dependent localization and effect on cell morphology. Nat Genet 31, 354–62.
Fields, R. D. and Stevens, B. (2000). ATP: an extracellular signaling molecule between neurons and glia. Trends Neurosci 23, 625–33.
Fields, R. D. and Stevens-Graham, B. (2002). New insights into neuron–glia communication. Science 298, 556–62.
Filbin, M. T., Walsh, F. S., Trapp, B. D., Pizzey, J. A. and Tennekoon, G. I. (1990). Role of myelin P0 protein as a homophilic adhesion molecule. Nature 344, 871–2.
Filbin, M. T., Zhang, K., Li, W. and Gao, Y. (1999). Characterization of the effect on adhesion of different mutations in myelin P0 protein. Ann NY Acad Sci 883, 160–7.
Fisher, M. (1956). Syndrome of ophthalmoplegia, ataxia and areflexia. New Engl J Med 255, 57–65.
Foote, A. K. and Blakemore, W. F. (2005). Inflammation stimulates remyelination in areas of chronic demyelination. Brain 128, 528–39.
Forsberg, E., Ek, B., Engstrom, A. and Johansson, S. (1994). Purification and characterization of integrin alpha 9 beta 1. Exp Cell Res 213, 183–90.
Fortun, J., Dunn, W. A. Jr., Joy, S., Li, J. and Notterpek, L. (2003). Emerging role for autophagy in the removal of aggresomes in Schwann cells. J Neurosci 23, 10672–80.
Fortun, J., Li, J., Go, J., Fenstermaker, A., Fletcher, B. S. and Notterpek, L. (2005). Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model. J Neurochem 92, 1531–41.
Fragoso, G., Robertson, J., Athlan, E., Tam, E., Almazan, G. and Mushynski, W. E. (2003). Inhibition of p38 mitogen-activated protein kinase interferes with cell shape changes and gene expression associated with Schwann cell myelination. Exp Neurol 183, 34–46.
Frampton, G., Winer, J. B., Cameron, J. S. and Hughes, R. A. (1988). Severe Guillain–Barré syndrome: an association with IgA anti-cardiolipin antibody in a series of 92 patients. J Neuroimmunol 19, 133–9.
Franklin, R. J. (2002). Remyelination of the demyelinated CNS: the case for and against transplantation of central, peripheral and olfactory glia. Brain Res Bull 57, 827–32.
Franzke, C. W., Tasanen, K., Schumann, H. and Bruckner-Tuderman, L. (2003). Collagenous transmembrane proteins: collagen XVII as a prototype. Matrix Biol 22, 299–309.
Frei, R., Dowling, J., Carenini, S., Fuchs, E. and Martini, R. (1999). Myelin formation by Schwann cells in the absence of beta4 integrin. Glia 27, 269–74.
French Cooperative Group on Plasma Exchange in Guillain–Barré syndrome (1987). Efficiency of plasma exchange in Guillain–Barré syndrome: role of replacement fluids. Ann Neurol 22, 753–61.
Frostick, S. P., Yin, Q. and Kemp, G. J. (1998). Schwann cells, neurotrophic factors, and peripheral nerve regeneration. Microsurgery 18, 397–405.
Fu, S. Y. and Gordon, T. (1997). The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 14, 67–116.
Fujii, K., Tsuji, M. and Murota, K. (1986). Isolation of peripheral nerve collagen. Neurochem Res 11, 1439–46.
Fujioka, T., Purev, E. and Rostami, A. (1999a). Chemokine mRNA expression in the cauda equina of Lewis rats with experimental allergic neuritis. J Neuroimmunol 97, 51–9.
Fujioka, T., Kolson, D. L. and Rostami, A. M. (1999b). Chemokines and peripheral nerve demyelination. J Neurovirol 5, 27–31.
Fuller, G. N., Spies, J. M., Pollard, J. D. and McLeod, J. G. (1994). Demyelinating neuropathies triggered by melanoma immunotherapy. Neurology 44, 2404–5.
Gaboreanu, A., Hrstka, R., Xu, al. (2004). A New Protein that Interacts with the Cytoplasmic Domain of P0. Am Society for Cell Biology Annual Meeting, Washington DC.
Gabriel, C. M., Hughes, R. A., Moore, S. E., Smith, K. J. and Walsh, F. S. (1998). Induction of experimental autoimmune neuritis with peripheral myelin protein-22. Brain 121 (Part 10), 1895–902.
Gabriel, C. M., Gregson, N. A. and Hughes, R. A. (2000). Anti-PMP22 antibodies in patients with inflammatory neuropathy. J Neuroimmunol 104, 139–46.
Gadient, R. A. and Otten, U. (1996). Postnatal expression of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia. Brain Res 724, 41–6.
Gambardella, A., Bono, F., Muglia, M., Valentino, P. and Quattrone, A. (1999). Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths (CMT4B). Ann NY Acad Sci 883, 47–55.
Garbay, B., Heape, A. M., Sargueil, F. and Cassagne, C. (2000). Myelin synthesis in the peripheral nervous system. Prog Neurobiol 61, 267–304.
Garbern, J. Y., Cambi, F., Tang, X. al. (1997). Proteolipid protein is necessary in peripheral as well as central myelin. Neuron 19, 205–18.
Garratt, A. N., Britsch, S. and Birchmeier, C. (2000a). Neuregulin, a factor with many functions in the life of a Schwann cell. Bioessays 22, 987–96.
Garratt, A. N., Voiculescu, O., Topilko, P., Charnay, P. and Birchmeier, C. (2000b). A dual role of erbB2 in myelination and in expansion of the Schwann cell precursor pool. J Cell Biol 148, 1035–46.
Gatto, C. L., Walker, B. J. and Lambert, S. (2003). Local ERM activation and dynamic growth cones at Schwann cell tips implicated in efficient formation of nodes of Ranvier. J Cell Biol 162, 489–98.
George, A., Schmidt, C., Weishaupt, A., Toyka, K. V. and Sommer, C. (1999). Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp Neurol 160, 124–32.
George, E. L., Georges-Labouesse, E. N., Patel-King, R. S., Rayburn, H. and Hynes, R. O. (1993). Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119, 1079–91.
Georges-Labouesse, E. N., George, E. L., Rayburn, H. and Hynes, R. O. (1996). Mesodermal development in mouse embryos mutant for fibronectin. Dev Dyn 207, 145–56.
Georgiou, J. and Charlton, M. P. (1999). Non-myelin-forming perisynaptic Schwann cells express protein zero and myelin-associated glycoprotein. Glia 27, 101–9.
Georgiou, J., Robitaille, R., Trimble, W. S. and Charlton, M. P. (1994). Synaptic regulation of glial protein expression in vivo. Neuron 12, 443–55.
Ghabriel, M. N. and Allt, G. (1981). Incisures of Schmidt–Lanterman. Prog Neurobiol 17, 25–58.
Ghazvini, M., Mandemakers, W., Jaegle, al. (2002). A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration. EMBO J 21, 4612–20.
Ghislain, J., Desmarquet-Trin-Dinh, C., Jaegle, M., Meijer, D., Charnay, P. and Frain, M. (2002). Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development. Development 129, 155–66.
Giese, K. P., Martini, R., Lemke, G., Soriano, P. and Schachner, M. (1992). Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71, 565–76.
Gillespie, C. S., Sherman, D. L., Blair, G. E. and Brophy, P. J. (1994). Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12, 497–508.
Girard, C., Bemelmans, A. P., Dufour, al. (2005). Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord. J Neurosci 25, 7924–33.
Girault, J. A., Oguievetskaia, K., Carnaud, M., Denisenko-Nehrbass, N. and Goutebroze, L. (2003). Transmembrane scaffolding proteins in the formation and stability of nodes of Ranvier. Biol Cell 95, 447–52.
Gleichmann, M., Gillen, C., Czardybon, al. (2000). Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur J Neurosci 12, 1857–66.
Godschalk, P. C., Heikema, A. P., Gilbert, al. (2004). The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain–Barré syndrome. J Clin Invest 114, 1659–65.
Gold, R., Toyka, K. V. and Hartung, H. P. (1995). Synergistic effect of IFN-gamma and TNF-alpha on expression of immune molecules and antigen presentation by Schwann cells. Cell Immunol 165, 65–70.
Gold, R., Archelos, J. J. and Hartung, H. P. (1999). Mechanisms of immune regulation in the peripheral nervous system. Brain Pathol 9, 343–60.
Gold, R., Hartung, H. P. and Toyka, K. V. (2000). Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today 6, 88–91.
Gollan, L., Salomon, D., Salzer, J. L. and Peles, E. (2003). Caspr regulates the processing of contactin and inhibits its binding to neurofascin. J Cell Biol 163, 1213–18.
Gonzalez-Martinez, T., Perez-Pinera, P., Diaz-Esnal, B. and Vega, J. A. (2003). S-100 proteins in the human peripheral nervous system. Microsc Res Tech 60, 633–8.
Goodyear, C. S., O'Hanlon, G. M., Plomp, J. al. (1999). Monoclonal antibodies raised against Guillain–Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle–nerve preparations. J Clin Invest 104, 697–708.
Gorson, K. C., Allam, G. and Ropper, A. H. (1997). Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 48, 321–8.
Gorson, K. C. and Chaudhry, V. (1999). Chronic inflammatory demyelinating polyneuropathy. Curr Treat Options Neurol 1, 251–62.
Gotz, M. (2003). Glial cells generate neurons – master control within CNS regions: developmental perspectives on neural stem cells. Neuroscientist 9, 379–97.
Gotz, M. and Barde, Y. A. (2005). Radial glial cells: defined and major intermediates between embryonic stem cells and CNS neurons. Neuron 46, 369–72.
Goutebroze, L., Carnaud, M., Denisenko, N., Boutterin, M. C. and Girault, J. A. (2003). Syndecan-3 and syndecan-4 are enriched in Schwann cell perinodal processes. BMC Neurosci 4, 29.
Greenfield, S., Brostoff, S., Eylar, E. H. and Morell, P. (1973). Protein composition of myelin of the peripheral nervous system. J Neurochem 20, 1207–16.
Gregorian, S. K., Lee, W. P., Beck, L. S., Rostami, A. and Amento, E. P. (1994). Regulation of experimental autoimmune neuritis by transforming growth factor-beta 1. Cell Immunol 156, 102–12.
Grewal, P. K., Holzfeind, P. J., Bittner, R. E. and Hewitt, J. E. (2001). Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat Genet 28, 151–4.
Grieco, T. M., Malhotra, J. D., Chen, C., Isom, L. L. and Raman, I. M. (2005). Open-channel block by the cytoplasmic tail of sodium channel β4 as a mechanism for resurgent sodium current. Neuron 45, 233–44.
Griffin, J. W. and Sheikh, K. (2005). The Guillain–Barré syndromes. Dyck, P. (Ed.) Peripheral Neuropathy, 4th Edn. Elsevier Saunders, Philadelphia, pp. 2197–219.
Griffin, J. W., Stoll, G., Li, C. Y., Tyor, W. and Cornblath, D. R. (1990). Macrophage responses in inflammatory demyelinating neuropathies. Ann Neurol 27 Suppl, S64–S68.
Griffin, J. W., George, R., Lobato, C., Tyor, W. R., Yan, L. C. and Glass, J. D. (1992). Macrophage responses and myelin clearance during Wallerian degeneration: relevance to immune-mediated demyelination. J Neuroimmunol 40, 153–65.
Griffin, J. W., George, R. and Ho, T. (1993a). Macrophage systems in peripheral nerves. A review. J Neuropathol Exp Neurol 52, 553–60.
Griffin, J. W., Kidd, G. J. and Trapp, B. D. (1993b). Interactions between axons and Schwann cells. Dyck, P. J., Thomas, P. K. (Eds.) Peripheral Neuropathy, 3rd Edn. WB Saunders, Philadelphia, pp. 317–30.
Griffin, J. W., Li, C. Y., Ho, T. al. (1995). Guillain–Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 118 (Part 3), 577–95.
Griffin, J. W., Li, C. Y., Ho, T. al. (1996a). Pathology of the motor-sensory axonal Guillain–Barré syndrome. Ann Neurol 39, 17–28.
Griffin, J. W., Li, C. Y., Macko, al. (1996b). Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain–Barré syndrome. J Neurocytol 25, 33–51.
Griffiths, I., Dickinson, P. and Montague, P. (1995). Expression of the proteolipid protein gene in glial cells of the post-natal peripheral nervous system of rodents. Neuropathol Appl Neurobiol 21, 97–110.
Griffiths, I., Klugmann, M., Anderson, T., Thomson, C., Vouyiouklis, D. and Nave, K. A. (1998). Current concepts of PLP and its role in the nervous system. Microsc Res Technique 41, 344–58.
Grim, M., Halata, Z. and Franz, T. (1992). Schwann cells are not required for guidance of motor nerves in the hindlimb in Splotch mutant mouse embryos. Anat Embryol 186, 311–18.
Grinspan, J. B., Marchionni, M. A., Reeves, M., Coulaloglou, M. and Scherer, S. S. (1996). Axonal interactions regulate Schwann cell apoptosis in developing peripheral nerve: neuregulin receptors and the role of neuregulins. J Neurosci 16, 6107–18.
Groneberg, D. A., Doring, F., Nickolaus, M., Daniel, H. and Fischer, A. (2001). Expression of PEPT2 peptide transporter mRNA and protein in glial cells of rat dorsal root ganglia. Neurosci Lett 304, 181–4.
Groschup, M. H., Beekes, M., McBride, P. A., Hardt, M., Hainfellner, J. A. and Budka, H. (1999). Deposition of disease-associated prion protein involves the peripheral nervous system in experimental scrapie. Acta Neuropathol (Berl) 98, 453–7.
Grothe, C., Meisinger, C., Hertenstein, A., Kurz, H. and Wewetzer, K. (1997). Expression of fibroblast growth factor-2 and fibroblast growth factor receptor 1 messenger RNAs in spinal ganglia and sciatic nerve: regulation after peripheral nerve lesion. Neuroscience 76, 123–35.
Guenard, V., Dinarello, C. A., Weston, P. J. and Aebischer, P. (1991). Peripheral nerve regeneration is impeded by interleukin-1 receptor antagonist released from a polymeric guidance channel. J Neurosci Res 29, 396–400.
Guenard, V., Rosenbaum, T., Gwynn, L. A., Doetschman, T., Ratner, N. and Wood, P. M. (1995a). Effect of transforming growth factor-beta 1 and -beta 2 on Schwann cell proliferation on neurites. Glia 13, 309–18.
Guenard, V., Gwynn, L. A. and Wood, P. M. (1995b). Transforming growth factor-beta blocks myelination but not ensheathment of axons by Schwann cells in vitro. J Neurosci 15, 419–28.
Guilbot, A., Williams, A., Ravise, al. (2001). A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot–Marie–Tooth disease. Hum Mol Genet 10, 415–21.
Guillain, G., Barré, J. A. and Strohl, A. (1916). Sur un syndrome de radiculo-névrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire. Remarques sur les caractéres cliniques et graphiques des réflexes tendineux. Bull Soc Méd Hôp Paris 40, 1462–70.
Guillain–Barré Syndrome Study Group (1985). Plasmapheresis and acute Guillain–Barré syndrome. Neurology 35, 1096–104.
Guiloff, R. J. (1977). Peripheral nerve conduction in Miller–Fisher syndrome. J Neurol Neurosurg Psychiatry 40, 801–7.
Haas, L. F. (1999). Neurological stamp. Theodore Schwann (1810–82). J Neurol Neurosurg Psychiatry 66, 103.
Hadden, R. D., Karch, H., Hartung, H. al. (2001). Preceding infections, immune factors, and outcome in Guillain–Barré syndrome. Neurology 56, 758–65.
Hafer-Macko, C., Hsieh, S. T., Li, C. al. (1996a). Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 40, 635–44.
Hafer-Macko, C. E., Sheikh, K. A., Li, C. al. (1996b). Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39, 625–35.
Hagedorn, L., Suter, U. and Sommer, L. (1999). P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors. Development 126, 3781–94.
Hagedorn, L., Paratore, C., Brugnoli, al. (2000). The Ets domain transcription factor Erm distinguishes rat satellite glia from Schwann cells and is regulated in satellite cells by neuregulin signaling. Dev Biol 219, 44–58.
Hahn, A. F. (1998). Guillain–Barré syndrome. Lancet 352, 635–41.
Hahn, A. F., Bolton, C. F., White, C. al. (1999). Genotype/phenotype correlations in X-linked dominant Charcot–Marie–Tooth disease. Ann NY Acad Sci 883, 366–82.
Hahn, A. F., Ainsworth, P. J., Naus, C. C., Mao, J. and Bolton, C. F. (2000). Clinical and pathological observations in men lacking the gap junction protein connexin 32. Muscle Nerve 23, S39–S48.
Hahn, A. F., Ainsworth, P. J., Bolton, C. F., Bilbao, J. M. and Vallat, J. M. (2001). Pathological findings in the x-linked form of Charcot–Marie–Tooth disease: a morphometric and ultrastructural analysis. Acta Neuropathol (Berl) 101, 129–39.
Hahn, A., Ciskind, C., Krajewski, K., Lewis, R. and Me, S. (2005). Genotype–phenotype correlations in CMTX1 (Abstract). J Peripher Nerv Syst 10 (Suppl 1), 31–2.
Halfter, W., Dong, S., Schurer, B. and Cole, G. J. (1998). Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J Biol Chem 273, 25404–12.
Hall, S. M. and Williams, P. L. (1970). Studies on the “incisures” of Schmidt and Lanterman. J Cell Sci 6, 767–91.
Hallows, J. L. and Tempel, B. L. (1998). Expression of Kv1.1, a Shaker-like potassium channel, is temporally regulated in embryonic neurons and glia. J Neurosci 18, 5682–91.
Halstead, S. K., O'Hanlon, G. M., Humphreys, P. al. (2004). Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain 127, 2109–23.
Halstead, S. K., Morrison, I., O'Hanlon, G. al. (2005). Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. Glia 52, 177–89.
Hammarberg, H., Lidman, O., Lundberg, al. (2000). Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 20, 5283–91.
Hanani, M., Huang, T. Y., Cherkas, P. S., Ledda, M. and Pannese, E. (2002). Glial cell plasticity in sensory ganglia induced by nerve damage. Neuroscience 114, 279–83.
Hanani, M. (2005). Satellite glial cells in sensory ganglia: from form to function. Brain Res Brain Res Rev 48, 457–76.
Hanemann, C. O., Bergmann, C., Senderek, J., Zerres, K. and Sperfeld, A. D. (2003). Transient, recurrent, white matter lesions in X-linked Charcot–Marie–Tooth disease with novel connexin 32 mutation. Arch Neurol 60, 605–9.
Harboe, M., Aseffa, A. and Leekassa, R. (2005). Challenges presented by nerve damage in leprosy. Lepr Rev 76, 5–13.
Harding, A. E. and Thomas, P. K. (1980a). Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J Med Genet 17, 329–36.
Harding, A. E. and Thomas, P. K. (1980b). The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103, 259–80.
Harrison, B. M., Hansen, L. A., Pollard, J. D. and McLeod, J. G. (1984). Demyelination induced by serum from patients with Guillain–Barré syndrome. Ann Neurol 15, 163–70.
Harrison, R. G. (1908). Embryonic transplantation and development of nervous system. Anat Rec 2, 385–410.
Harrison, R. G. (1924). Neuroblast versus sheath cell in the development of peripheral nerves. J Comp Neurol 37, 123–205.
Hartung, H. P., Pollard, J. D., Harvey, G. K. and Toyka, K. V. (1995a). Immunopathogenesis and treatment of the Guillain–Barré syndrome–Part II. Muscle Nerve 18, 154–64.
Hartung, H. P., Pollard, J. D., Harvey, G. K. and Toyka, K. V. (1995b). Immunopathogenesis and treatment of the Guillain–Barré syndrome–Part I. Muscle Nerve 18, 137–153.
Hartung, H. P., Zielasek, J., Jung, S. and Toyka, K. V. (1996a). Effector mechanisms in demyelinating neuropathies. Rev Neurol (Paris) 152, 320–7.
Hartung, H. P., Kiefer, R., Gold, R. and Toyka, K. V. (1996b). Autoimmunity in the peripheral nervous system. Baillieres Clin Neurol 5, 1–45.
Hartung, H. P., Willison, H., Jung, S., Pette, M., Toyka, K. V. and Giegerich, G. (1996c). Autoimmune responses in peripheral nerve. Springer Semin Immunopathol 18, 97–123.
Hartung, H. P., Meche, F. G. and Pollard, J. D. (1998). Guillain–Barré syndrome, CIDP and other chronic immune-mediated neuropathies. Curr Opin Neurol 11, 497–513.
Harvey, G. K., Pollard, J. D., Schindhelm, K. and Antony, J. (1987). Chronic experimental allergic neuritis. An electrophysiological and histological study in the rabbit. J Neurol Sci 81, 215–25.
Harvey, G. K., Toyka, K. V., Zielasek, J., Kiefer, R., Simonis, C. and Hartung, H. P. (1995). Failure of anti-GM1 IgG or IgM to induce conduction block following intraneural transfer. Muscle Nerve 18, 388–94.
Hase, A., Saito, F., Yamada, H., Arai, K., Shimizu, T. and Matsumura, K. (2005). Characterization of glial cell line-derived neurotrophic factor family receptor alpha-1 in peripheral nerve Schwann cells. J Neurochem 95, 537–43.
Hassan, S. M., Jennekens, F. G., Veldman, H. and Oestreicher, B. A. (1994). GAP-43 and p75NGFR immunoreactivity in presynaptic cells following neuromuscular blockade by botulinum toxin in rat. J Neurocytol 23, 354–63.
Hatton, G. I. and Parpura, V. (2004). Glial Neuronal Signaling. Kluwer Academic Publishers, Boston.
Haydon, P. G. (2001). Glia: listening and talking to the synapse. Nat Rev Neurosci 2, 185–93.
Hays, A. P., Lee, S. S. and Latov, N. (1988). Immune reactive C3d on the surface of myelin sheaths in neuropathy. J Neuroimmunol 18, 231–44.
Hayworth, C. R., Moody, S. E., Chodosh, L. A., Krieg, P. A., Rimer, M. and Thompson, W. (2006). Induction of neuregulin signaling in mouse Schwann cells in vivo mimics responses to denervation J Neurosci26, 6873–84.
Herrera, A. A., Banner, L. R. and Nagaya, N. (1990). Repeated, in vivo observation of frog neuromuscular junctions: remodelling involves concurrent growth and retraction. J Neurocytol 19, 85–99.
Herrera, A. A., Qiang, H. and Ko, C. P. (2000). The role of perisynaptic Schwann cells in development of neuromuscular junctions in the frog (Xenopus laevis). J Neurobiol 45, 237–54.
Heumann, R., Lindholm, D., Bandtlow, al. (1987a). Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: role of macrophages. Proc Nat Acad Sci USA 84, 8735–9.
Heumann, R., Korsching, S., Bandtlow, C. and Thoenen, H. (1987b). Changes of nerve growth factor synthesis in nonneuronal cells in response to sciatic nerve transection. J Cell Biol 104, 1623–31.
Heuser, J. E., Reese, T. S. and Landis, D. M. (1976). Preservation of synaptic structure by rapid freezing. Cold Spring Harb Symp Quant Biol 40, 17–24.
Heuss, D., Engelhardt, A., Gobel, H. and Neundorfer, B. (1995). Light-microscopic study of phosphoprotein B-50 in myopathies. Virchows Arch 426, 69–76.
Hill, C. E., Moon, L. D., Wood, P. M. and Bunge, M. B. (2006). Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival. Glia 53, 338–43.
Hirata, K., Zhou, C., Nakamura, K. and Kawabuchi, M. (1997). Postnatal development of Schwann cells at neuromuscular junctions, with special reference to synapse elimination. J Neurocytol 26, 799–809.
Hirata, K., Mitoma, H., Ueno, N., He, J. W. and Kawabuchi, M. (1999). Differential response of macrophage subpopulations to myelin degradation in the injured rat sciatic nerve. J Neurocytol 28, 685–95.
Hirota, H., Kiyama, H., Kishimoto, T. and Taga, T. (1996). Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J Exp Med 183, 2627–34.
Hisahara, S., Shoji, S., Okano, H. and Miura, M. (1997). ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J Neurochem 69, 10–20.
Ho, T. W., Mishu, B., Li, C. al. (1995). Guillain–Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118 (Part 3), 597–605.
Ho, T. W., Hsieh, S. T., Nachamkin, al. (1997a). Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 48, 717–24.
Ho, T. W., Li, C. Y., Cornblath, D. al. (1997b). Patterns of recovery in the Guillain–Barré syndromes. Neurology 48, 695–700.
Ho, T. W., McKhann, G. M. and Griffin, J. W. (1998). Human autoimmune neuropathies. Ann Rev Neurosci 21, 187–226.
Ho, T. W., Willison, H. J., Nachamkin, al. (1999). Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain–Barré syndrome. Ann Neurol 45, 168–73.
Hodgkinson, S. J., Westland, K. W. and Pollard, J. D. (1994). Transfer of experimental allergic neuritis by intra neural injection of sensitized lymphocytes. J Neurol Sci 123, 162–72.
Hoebe, K., Janssen, E. and Beutler, B. (2004). The interface between innate and adaptive immunity. Nat Immunol 5, 971–4.
Hofler, H., Walter, G. F. and Denk, H. (1984). Immunohistochemistry of folliculo-stellate cells in normal human adenohypophyses and in pituitary adenomas. Acta Neuropathol (Berl) 65, 35–40.
Hoke, A. and Keswani, S. C. (2005). Neuroprotection in the PNS: erythropoietin and immunophilin ligands. Ann NY Acad Sci 1053, 491–501.
Hoke, A., Ho, T., Crawford, T. O., Lebel, C., Hilt, D. and Griffin, J. W. (2003). Glial cell line-derived neurotrophic factor alters axon Schwann cell units and promotes myelination in unmyelinated nerve fibers. J Neurosci 23, 561–7.
Holen, T. and Mobbs, C. V. (2004). Lobotomy of genes: use of RNA interference in neuroscience. Neurosci 126, 1–7.
Holland, N. R., Crawford, T. O., Hauer, P., Cornblath, D. R., Griffin, J. W. and McArthur, J. C. (1998). Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 44, 47–59.
Homma, S., Yaginuma, H. and Oppenheim, R. W. (1994). Programmed cell death during the earliest stages of spinal cord development in the chick embryo: a possible means of early phenotypic selection. J Comp Neurol 345, 377–95.
Hong, C. S. and Saint-Jeannet, J. P. (2005). Sox proteins and neural crest development. Semin Cell Dev Biol 16, 694–703.
Hoogendijk, J. E., Janssen, E. A., Gabreels-Festen, A. al. (1993). Allelic heterogeneity in hereditary motor and sensory neuropathy type Ia (Charcot–Marie–Tooth disease type 1a). Neurology 43, 1010–15.
Houlden, H., King, R. H., Wood, N. W., Thomas, P. K. and Reilly, M. M. (2001). Mutations in the 5′ region of the myotubularin-related protein 2 (MTMR2) gene in autosomal recessive hereditary neuropathy with focally folded myelin. Brain 124, 907–15.
Hsiao, L. L., Peltonen, J., Jaakkola, S., Gralnick, H., Uitto, J. (1991). Plasticity of integrin expression by nerve-derived connective tissue cells. Human Schwann cells, perineurial cells, and fibroblasts express markedly different patterns of beta 1 integrins during nerve development, neoplasia, and in vitro. J Clin Invest 87, 811–20.
Hsieh, S. T., Kidd, G. J., Crawford, T. al. (1994). Regional modulation of neurofilament organization by myelination in normal axons. J Neurosci 14, 6392–401.
Hu, H. M., O'Rourke, K., Boguski, M. S. and Dixit, V. M. (1994). A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem 269, 30069–72.
Hu, W., Ramacher, M., Hartung, H.-P. and Kieseier, B. C. (2004). Schwann cells express Toll-like receptors. J Neuroimmunol 154, 48.
Huang, E. J. and Reichardt, L. F. (2001). Neurotrophins: roles in neuronal development and function. Ann Rev Neurosci 24, 677–736.
Hughes, B. W., Kusner, L. L. and Kaminski, H. J. (2005a). Molecular architecture of the neuromuscular junction. Muscle Nerve 33, 445–61.
Hughes, P. M., Wells, G. M., Clements, J. al. (1998). Matrix metalloproteinase expression during experimental autoimmune neuritis. Brain 121 (Part 3), 481–94.
Hughes, R. (1990). Guillain–Barré Syndrome. Springer-Verlag, Heidelberg.
Hughes, R. (2004). Treatment of Guillain–Barré syndrome with corticosteroids: lack of benefit?Lancet 363, 181–2.
Hughes, R. and Meche, F. G. (2000). Corticosteroids for treating Guillain–Barré syndrome. Cochrane Database Syst Rev CD001446.
Hughes, R., Sanders, E., Hall, S., Atkinson, P., Colchester, A. and Payan, P. (1992). Subacute idiopathic demyelinating polyradiculoneuropathy. Arch Neurol 49, 612–16.
Hughes, R., Atkinson, P. F., Gray, I. A. and Taylor, W. A. (1987). Major histocompatibility antigens and lymphocyte subsets during experimental allergic neuritis in the Lewis rat. J Neurol 234, 390–5.
Hughes, R., Hadden, R. D., Gregson, N. A. and Smith, K. J. (1999). Pathogenesis of Guillain–Barré syndrome. J Neuroimmunol 100, 74–97.
Hughes, R., Raphael, J. C., Swan, A. V. and Doorn, P. A. (2001). Intravenous immunoglobulin for Guillain–Barré syndrome. Cochrane Database Syst Rev CD002063.
Hughes, R., Swan, A. V. and Doorn, P. A. (2003). Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev CD003280.
Hughes, R. A., Wijdicks, E. F., Benson, al. (2005a). Supportive care for patients with Guillain–Barré syndrome. Arch Neurol 62, 1194–8.
Hughes, R. A. C., Bouche, P., Cornblath, D. al. (2005b). European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 10, 220–8.
Huxley, C., Passage, E., Manson, al. (1996). Construction of a mouse model of Charcot–Marie–Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 5, 563–9.
Hyland, H. H. and Russell, W. R. (1930). Chronic progressive polyneuritis with report of a fatal case. Brain 53, 278–9.
Hynes, R. O. (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11–25.
Ichimura, T. and Ellisman, M. H. (1991). Three-dimensional fine structure of cytoskeletal–membrane interactions at nodes of Ranvier. J Neurocytol 20, 667–81.
Ilyas, A. A., Mithen, F. A., Dalakas, M. al. (1991). Antibodies to sulfated glycolipids in Guillain–Barré syndrome. J Neurol Sci 105, 108–17.
Ilyas, A. A., Mithen, F. A., Dalakas, M. C., Chen, Z. W. and Cook, S. D. (1992). Antibodies to acidic glycolipids in Guillain–Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 107, 111–21.
Imamura, M., Araishi, K., Noguchi, S. and Ozawa, E. (2000). A sarcoglycan–dystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system. Hum Mol Genet 9, 3091–100.
Inoue, K., Tanabe, Y. and Lupski, J. R. (1999). Myelin deficiencies in both the central and the peripheral nervous systems associated with a SOX10 mutation. Ann Neurol 46, 313–18.
Inoue, K., Shilo, K., Boerkoel, C. al. (2002). Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg–Hirschsprung disease: phenotypes linked by SOX10 mutation. Ann Neurol 52, 836–42.
Inoue, K., Khajavi, M., Ohyama, al. (2004). Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet 36, 361–9.
Ionasescu, V. V., Ionasescu, R., Searby, C. and Neahring, R. (1995). Dejerine–Sottas disease with de novo dominant point mutation of the PMP22 gene. Neurology 45, 1766–7.
Ishikawa, S., Ohshima, Y., Suzuki, T. and Oboshi, S. (1979). Primitive neuroectodermal tumor (neuroepithelioma) of spinal nerve root – report of an adult case and establishment of a cell line. Acta Pathol Jpn 29, 289–301.
Ivanova, A. and Nachev, S. (1990). Morphological changes in the nervous system in lead poisoning. I. Experimentally induced lead neuropathy. Eksp Med Morfol 29, 18–23.
Iwasaki, A. and Medzhitov, R. (2004). Toll-like receptor control of the adaptive immune responses. Nat Immunol 5, 987–95.
Iwase, T., Jung, C. G., Bae, H., Zhang, M. and Soliven, B. (2005). Glial cell line-derived neurotrophic factor-induced signaling in Schwann cells. J Neurochem 94, 1488–99.
Jaakkola, S., Peltonen, J. and Uitto, J. J. (1989). Perineurial cells coexpress genes encoding interstitial collagens and basement membrane zone components. J Cell Biol 108, 1157–63.
Jacobs, B. C., Endtz, H., Meche, F. G., Hazenberg, M. P., Achtereekte, H. A. and Doorn, P. A. (1995). Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller–Fisher syndrome. Ann Neurol 37, 260–4.
Jacobs, J. M. and Love, S. (1985). Qualitative and quantitative morphology of human sural nerve at different ages. Brain 108 (Part 4), 897–924.
Jaegle, M., Mandemakers, W., Broos, al. (1996). The POU factor Oct-6 and Schwann cell differentiation. Science 273, 507–10.
Jaegle, M., Ghazvini, M., Mandemakers, al. (2003). The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development. Genes & Development 17, 1380–91.
Jahromi, B. S., Robitaille, R. and Charlton, M. P. (1992). Transmitter release increases intracellular calcium in perisynaptic Schwann cells in situ. Neuron 8, 1069–77.
James, S., Patel, N. J., Thomas, P. K. and Burnstock, G. (1993). Immunocytochemical localisation of insulin receptors on rat superior cervical ganglion neurons in dissociated cell culture. J Anat 182 (Part 1), 95–100.
Jander, S., Bussini, S., Neuen-Jacob, al. (2002). Osteopontin: a novel axon-regulated Schwann cell gene. J Neurosci Res 67, 156–66.
Janeway, C. A. Jr. (1992). The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 13, 11–16.
Jaros, E. and Bradley, W. G. (1978). Development of the amyelinated lesion in the ventral root of the dystrophic mouse. Ultrastructural, quantitative and autoradiographic study. J Neurol Sci 36, 317–39.
Jaros, E. and Bradley, W. G. (1979). Atypical axon–Schwann cell relationships in the common peroneal nerve of the dystrophic mouse: an ultrastructural study. Neuropathol Appl Neurobiol 5, 133–47.
Jessen, K. R. (2004). Glial cells. Int J Biochem Cell Biol 36, 1861–7.
Jessen, K. R. and Mirsky, R. (1980). Glial cells in the enteric nervous system contain glial fibrillary acidic protein. Nature 286, 736–7.
Jessen, K. R. and Mirsky, R. (1985). Glial fibrillary acidic polypeptides in peripheral glia. Molecular weight, heterogeneity and distribution. J Neuroimmunol 8, 377–93.
Jessen, K. R. and Mirsky, R. (1999). Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci 22, 402–10.
Jessen, K. R. and Mirsky, R. (2002). Signals that determine Schwann cell identity. J Anat 200, 367–75.
Jessen, K. R. and Mirsky, R. (2004). Schwann cell development. Lazzarini, R. A. (Ed.) Myelin Biology and Disorders. Elsevier, Philadelphia, pp. 329–59.
Jessen, K. R. and Mirsky, R. (2005a). The origin and development of glial cells in peripheral nerves. Nature Rev Neurosci 6, 671–82.
Jessen, K. R. and Mirsky, R. (2005b). The Schwann cell lineage. Kettenmann, H., Ransom, B. (Eds.) Neuroglia, 2 Edn. Oxford University Press, Oxford, pp. 85–100.
Jessen, K. R., Morgan, L., Stewart, H. J. S. and Mirsky, R. (1990). Three markers of adult non-myelin-forming Schwann cells, 217c (Ran-1), A5E3 and GFAP: development and regulation by neuron–Schwann cell interactions. Development 109, 91–103.
Jessen, K. R., Brennan, A., Morgan, al. (1994). The Schwann cell precursor and its fate: a study of cell death and differentiation during gliogenesis in rat embryonic nerves. Neuron 12, 509–27.
John, G. R., Shankar, S. L., Shafit-Zagardo, al. (2002). Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8, 1115–21.
Johnson, A. N. and Newfeld, S. J. (2002). The TGF-beta family: signaling pathways, developmental roles, and tumor suppressor activities. Scientific World J 2, 892–925.
Jones, L. L., Sajed, D. and Tuszynski, M. H. (2003). Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition. J Neurosci 23, 9276–88.
Jones, P. L. and Jones, F. S. (2000). Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol 19, 581–96.
Jordan, C. L. and Williams, T. J. (2001). Testosterone regulates terminal Schwann cell number and junctional size during developmental synapse elimination. Dev Neurosci 23, 441–51.
Joseph, N. M., Mukouyama, Y. S., Mosher, J. al. (2004). Neural crest stem cells undergo multilineage differentiation in developing peripheral nerves to generate endoneurial fibroblasts in addition to Schwann cells. Development 131, 5599–612.
Kadlubowski, M. and Hughes, R. A. (1979). Identification of the neuritogen for experimental allergic neuritis. Nature 277, 140–1.
Kadlubowski, M. and Hughes, R. A. (1980). The neuritogenicity and encephalitogenicity of P2 in the rat, guinea-pig and rabbit. J Neurol Sci 48, 171–8.
Kaelin-Lang, A., Lauterburg, T. and Burgunder, J. M. (1998). Expression of adenosine A2a receptor gene in rat dorsal root and autonomic ganglia. Neurosci Lett 246, 21–4.
Kameda, Y. (1996). Immunoelectron microscopic localization of vimentin in sustentacular cells of the carotid body and the adrenal medulla of guinea pigs. J Histochem Cytochem 44, 1439–49.
Kang, H., Tian, L. and Thompson, W. (2003). Terminal Schwann cells guide the reinnervation of muscle after nerve injury. J Neurocytol 32, 975–85.
Katz, R. L. (1966). Nerve, Muscle and Synapse. McGraw-Hill, New York.
Kawabuchi, M., Zhou, C. J., Wang, S., Nakamura, K., Liu, W. T. and Hirata, K. (2001). The spatiotemporal relationship among Schwann cells, axons and postsynaptic acetylcholine receptor regions during muscle reinnervation in aged rats. Anat Rec 264, 183–202.
Kelly, A. M. and Zacks, S. I. (1969). The fine structure of motor endplate morphogenesis. J Cell Biol 42, 154–69.
Kennedy, W. R. (2004). Opportunities afforded by the study of unmyelinated nerves in skin and other organs. Muscle Nerve 29, 756–67.
Kennedy, W. R., Wendelschafer-Crabb, G. and Johnson, T. (1996). Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47, 1042–8.
Kerschensteiner, M., Stadelmann, C., Dechant, G., Wekerle, H. and Hohlfeld, R. (2003). Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann Neurol 53, 292–304.
Kettenmann, H. and Ransom, B. R. (2005). Neuroglia, 2nd Edn. Oxford University Press, New York.
Keynes, R. J. (1987). Schwann cells during neural development and regeneration: leaders or followers?Trends Neurosci 10, 137–9.
Khalili-Shirazi, A., Hughes, R. A., Brostoff, S. W., Linington, C. and Gregson, N. (1992). T cell responses to myelin proteins in Guillain–Barré syndrome. J Neurol Sci 111, 200–3.
Khalili-Shirazi, A., Atkinson, P., Gregson, N. and Hughes, R. A. (1993). Antibody responses to P0 and P2 myelin proteins in Guillain–Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J Neuroimmunol 46, 245–51.
Kiefer, R., Streit, W. J., Toyka, K. V., Kreutzberg, G. W. and Hartung, H. P. (1995). Transforming growth factor-beta 1: a lesion-associated cytokine of the nervous system. Int J Dev Neurosci 13, 331–9.
Kiefer, R., Funa, K., Schweitzer, al. (1996). Transforming growth factor-beta 1 in experimental autoimmune neuritis. Cellular localization and time course. Am J Pathol 148, 211–23.
Kiefer, R., Kieseier, B. C., Stoll, G. and Hartung, H. P. (2001). The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol 64, 109–27.
Kieseier, B. C., Krivacic, K., Jung, al. (2000). Sequential expression of chemokines in experimental autoimmune neuritis. J Neuroimmunol 110, 121–9.
Kieseier, B. C., Dalakas, M. C. and Hartung, H. P. (2002a). Immune mechanisms in chronic inflammatory demyelinating neuropathy. Neurology 59, S7–S12.
Kieseier, B. C., Tani, M., Mahad, al. (2002b). Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain 125, 823–34.
Kieseier, B. C., Kiefer, R., Gold, R., Hemmer, B., Willison, H. J. and Hartung, H. P. (2004). Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30, 131–56.
Kim, S. A., Vacratsis, P. O., Firestein, R., Cleary, M. L. and Dixon, J. E. (2003). Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase. Proc Nat Acad Sci USA 100, 4492–7.
Kim, S. I., Voshol, H., , O. J., Hastings, T. G., Cascio, M. and Glucksman, M. J. (2004). Neuroproteomics: expression profiling of the brain's proteomes in health and disease. Neurochem Res 29, 1317–31.
Kingsley, D. M. (1994). The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8, 133–46.
Kingston, A. E., Bergsteinsdottir, K., Jessen, K. R., Meide, P. H., Colston, M. J. and Mirsky, R. (1989). Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction. Eur J Immunol 19, 177–83.
Kinugasa, Y., Ishiguro, H., Tokita, Y., Oohira, A., Ohmoto, H. and Higashiyama, S. (2004). Neuroglycan C, a novel member of the neuregulin family. Biochem Biophys Res Commun 321, 1045–9.
Kioussi, C., Gross, M. K. and Gruss, P. (1995). Pax3: A paired domain gene as a regulator in PNS myelination. Neuron 15, 553–62.
Kirschner, D. A., Wrabetz, L. and Feltri, M. L. (2004). The P0 gene. Lazzarini, R. L. (Ed.) Myelin Biology and Disorders. Elsevier, Philadelphia, pp. 523–45.
Ko, C. P. (1981). Electrophysiological and freeze-fracture studies of changes following denervation at frog neuromuscular junctions. J Physiol 321, 627–39.
Ko, C. P. (1987). A lectin, peanut agglutinin, as a probe for the extracellular matrix in living neuromuscular junctions. J Neurocytol 16, 567–76.
Ko, C. P. and Chen, L. (1996). Synaptic remodeling revealed by repeated in vivo observations and electron microscopy of identified frog neuromuscular junctions. J Neurosci 16, 1780–90.
Ko, C. P. and Thompson, W. (2003). Special issue – the neuromuscular junction. J Neurocytol 32, 423–1037.
Kocsis, J. D., Akiyama, Y. and Radtke, C. (2004). Neural precursors as a cell source to repair the demyelinated spinal cord. J Neurotrauma 21, 441–9.
Koenig, H. L., Schumacher, M., Ferzaz, al. (1995). Progesterone synthesis and myelin formation by Schwann cells. Science 268, 1500–3.
Koirala, S. and Ko, C. P. (2004). Pruning an axon piece by piece: a new mode of synapse elimination. Neuron 44, 578–80.
Koirala, S., Qiang, H. and Ko, C. P. (2000). Reciprocal interactions between perisynaptic Schwann cells and regenerating nerve terminals at the frog neuromuscular junction. J Neurobiol 44, 343–60.
Koirala, S., Reddy, L. V. and Ko, C. P. (2003). Roles of glial cells in the formation, function, and maintenance of the neuromuscular junction. J Neurocytol 32, 987–1002.
Koller, H., Giesen, H. J. and Siebler, M. (1995). Impairment of electrophysiological function of astrocytes by cerebrospinal fluid from a patient with Waldenstrom's macroglobulinemia. J Neuroimmunol 61, 35–9.
Koller, H., Kieseier, B. C., Jander, S. and Hartung, H. P. (2005). Chronic inflammatory demyelinating polyneuropathy. N Engl J Med 352, 1343–56.
Koski, C. L. (1997). Mechanisms of Schwann cell damage in inflammatory neuropathy. J Infect Dis 176 (Suppl 2), S169–S172.
Koski, C. L., Humphrey, R. and Shin, M. L. (1985). Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation. Proc Nat Acad Sci USA 82, 905–9.
Koski, C. L., Sanders, M. E., Swoveland, P. al. (1987). Activation of terminal components of complement in patients with Guillain–Barré syndrome and other demyelinating neuropathies. J Clin Invest 80, 1492–7.
Krajewski, K., Turansky, C., Lewis, al. (1999). Correlation between weakness and axonal loss in patients with CMT1A. Ann NY Acad Sci 883, 490–2.
Krajewski, K. M., Lewis, R. A., Fuerst, D. al. (2000). Neurological dysfunction and axonal degeneration in Charcot–Marie–Tooth disease type 1A. Brain 123, 1516–27.
Kramer, R. H., Cheng, Y. F. and Clyman, R. (1990). Human microvascular endothelial cells use beta 1 and beta 3 integrin receptor complexes to attach to laminin. J Cell Biol 111, 1233–43.
Krammer, P. H. (2000). CD95's deadly mission in the immune system. Nature 407, 789–95.
Kreusch, A., Pfaffinger, P. J., Stevens, C. F. and Choe, S. (1998). Crystal structure of the tetramerization domain of the Shaker potassium channel. Nature 392, 945–8.
Kritas, S. K., Pensaert, M. B., Nauwynck, H. J. and Kyriakis, S. C. (1999). Neural invasion of two virulent suid herpesvirus 1 strains in neonatal pigs with or without maternal immunity. Vet Microbiol 69, 143–56.
Krucke, W. (1955). Evkrankungen des peripheren nerven systems. Evkrankungen der peripheren nerve. Lubarsch, O., Henke, F., Rossle, R. (Eds.) Handbuck der Speziellen Pathologischen Anatomie und Histologie, 13 Springer-Verlag, Berlin, pp. 164–83.
Kubu, C. J., Orimoto, K., Morrison, S. J., Weinmaster, G., Anderson, D. J. and Verdi, J. M. (2002). Developmental changes in Notch1 and Numb expression mediated by local cell–cell interactions underlie progressively increasing delta sensitivity in neural crest stem cells. Develop Biol 244, 199–214.
Kuffler, D. P. (1986). Accurate reinnervation of motor end plates after disruption of sheath cells and muscle fibers. J Comp Neurol 250, 228–35.
Kullberg, R. W., Lentz, T. L. and Cohen, M. W. (1977). Development of the myotomal neuromuscular junction in Xenopus laevis: an electrophysiological and fine-structural study. Dev Biol 60, 101–29.
Kumpulainen, T. and Korhonen, L. K. (1982). Immunohistochemical localization of carbonic anhydrase isoenzyme C in the central and peripheral nervous system of the mouse. J Histochem Cytochem 30, 283–92.
Kurtz, A., Zimmer, A., Schnutgen, F., Bruning, G., Spener, F. and Muller, T. (1994). The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development. Development 120, 2637–49.
Kury, P., Koller, H., Hamacher, M., Cornely, C., Hasse, B. and Muller, H. W. (2003). Cyclic AMP and tumor necrosis factor-alpha regulate CXCR4 gene expression in Schwann cells. Mol Cell Neurosci 24, 1–9.
Kusunoki, S., Chiba, A., Hitoshi, S., Takizawa, H. and Kanazawa, I. (1995). Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection. Muscle Nerve 18, 409–13.
Kuwabara, S., Ogawara, K., Misawa, al. (2004). Does Campylobacter jejuni infection elicit ‘demyelinating’ Guillain–Barré syndrome?Neurology 63, 529–33.
Kwa, M. S., , S. I., Brand, A., Baas, F. and Vermeulen, M. (2001). Investigation of serum response to PMP22, connexin 32 and P(0) in inflammatory neuropathies. J Neuroimmunol 116, 220–25.
Kwa, M. S., Van, S. I., Jonge, R. al. (2003). Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies. Brain 126, 361–75.
La, F. M., Underwood, J. L., Rappolee, D. A. and Werb, Z. (1996). Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 184, 2311–26.
Lacas-Gervais, S., Guo, J., Strenzke, al. (2004). βIVΣ1 spectrin stabilizes the nodes of Ranvier and axon initial segments. J Cell Biol 166, 983–90.
Lambert, S., Davis, J. Q. and Bennett, V. (1997). Morphogenesis of the node of Ranvier: co-clusters of ankyrin and ankyrin-binding integral proteins define early developmental intermediates. J Neurosci 17, 7025–36.
Lampert, P. W. (1969). Mechanism of demyelination in experimental allergic neuritis. Electron microscopic studies. Lab Invest 20, 127–38.
Laporte, J., Blondeau, F., Buj-Bello, A. and Mandel, J. L. (2001). The myotubularin family: from genetic disease to phosphoinositide metabolism. Trends Genet 17, 221–8.
Latov, N. (2002). Diagnosis of CIDP. Neurology 59, S2–S6.
Lazarini, F., Tham, T. N., Casanova, P., Renzana-Seisdedos, F. and Dubois-Dalcq, M. (2003). Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 42, 139–48.
Douarin, N. M. and Dupin, E. (1993). Cell lineage analysis in neural crest ontogeny. J Neurobiol 24, 146–61.
Douarin, N. M. and Kalcheim, C. (1999). The Neural Crest. Cambridge University Press, Cambridge.
Le, N., Nagarajan, R., Wang, J. Y. al. (2005a). Nab proteins are essential for peripheral nervous system myelination. Nat Neurosci 8, 932–40.
Le, N., Nagarajan, R., Wang, J. Y. T., Araki, T., Schmidt, R. E. and Milbrandt, J. (2005b). Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Nat Acad Sci USA 102, 2596–601.
Lee, M. J., Brennan, A., Blanchard, al. (1997). P0 is constitutively expressed in the rat neural crest and embryonic nerves and is negatively and positively regulated by axons to generate non-myelin-forming and myelin-forming Schwann cells, respectively. Mol Cell Neurosci 8, 336–50.
Lefcort, F., Venstrom, K., McDonald, J. A. and Reichardt, L. F. (1992). Regulation of expression of fibronectin and its receptor, alpha 5 beta 1, during development and regeneration of peripheral nerve. Development 116, 767–82.
Leimeroth, R., Lobsiger, C., Lussi, A., Taylor, V., Suter, U. and Sommer, L. (2002). Membrane-bound neuregulin1 type III actively promotes Schwann cell differentiation of multipotent progenitor cells. Develop Biol 246, 245–58.
Lemke, G. (2001). Glial control of neuronal development. Ann Rev Neurosci 24, 87–105.
Lemke, G. and Axel, R. (1985). Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 40, 501–8.
Lentz, S. I., Miner, J. H., Sanes, J. R. and Snider, W. D. (1997). Distribution of the ten known laminin chains in the pathways and targets of developing sensory axons. J Comp Neurol 378, 547–61.
Leppert, D., Hughes, P., Huber, al. (1999). Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy. Neurology 53, 62–70.
Letinsky, M. S., Fischbeck, K. H. and McMahan, U. J. (1976). Precision of reinnervation of original postsynaptic sites in frog muscle after a nerve crush. J Neurocytol 5, 691–718.
Levedakou, E. N., Chen, X. J., Soliven, B. and Popko, B. (2005). Disruption of the mouse Large gene in the enr and myd mutants results in nerve, muscle, and neuromuscular junction defects. Mol Cell Neurosci 28, 757–69.
Lewis, J., Al-Ghaith, L., Swanson, G. and Khan, A. (1983). The control of axon outgrowth in the developing chick wing. Prog Clin Biol Res 110 (Part A), 195–205.
Lewis, R. A. and Shy, M. E. (1999). Electrodiagnostic findings in CMTX: a disorder of the Schwann cell and peripheral nerve myelin. Ann NY Acad Sci 883, 504–7.
Li, J., Krajewski, K., Shy, M. E. and Lewis, R. A. (2002a). Hereditary neuropathy with liability to pressure palsy: the electrophysiology fits the name. Neurology 58, 1769–73.
Li, J., Krajewski, K., Lewis, R. A. and Shy, M. E. (2004). Loss-of-function phenotype of hereditary neuropathy with liability to pressure palsies. Muscle Nerve 29, 205–10.
Li, J., Bai, Y., Ghandour, K., Qin, al. (2005a). Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. Brain 128, 1168–77.
Li, J., Grandis, M., Trostinskaia, A. et al. 32765. Intralaminar protein accumulation of myelin and axonal degeneration in a human MPZ mutation: an autopsy study.
Li, L., Xian, C. J., Zhong, J. H. and Zhou, X. F. (2003). Lumbar 5 ventral root transection-induced upregulation of nerve growth factor in sensory neurons and their target tissues: a mechanism in neuropathic pain. Mol Cell Neurosci 23, 232–50.
Li, Q., Shirabe, K., Thisse, al. (2005b). Chemokine signaling guides axons within the retina in zebrafish. J Neurosci 25, 1711–17.
Li, S., Liquari, P., McKee, K. al. (2005c). Laminin-sulfatide binding initiates basement membrane assembly and enables receptor signaling in Schwann cells and fibroblasts. J Cell Biol 169, 179–89.
Li, X., Lynn, B. D., Olson, al. (2002b). Connexin29 expression, immunocytochemistry and freeze-fracture replica immunogold labelling (FRIL) in sciatic nerve. Eur J Neurosci 16, 795–806.
Li, X., Gonias, S. L. and Campana, W. M. (2005d). Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury. Glia 51, 254–65.
Li, J., Bai, Y. and Ianakova, al. (2006). Major myelin protein gene (PO) mutation causes a novel form of axonal degeneration. J Comp Neurol 498, 252–65.
Lichtman, J. W. and Sanes, J. R. (2003). Watching the neuromuscular junction. J Neurocytol 32, 767–75.
Lichtman, J. W., Magrassi, L. and Purves, D. (1987). Visualization of neuromuscular junctions over periods of several months in living mice. J Neurosci 7, 1215–22.
Lilje, O. (2002). The processing and presentation of endogenous and exogenous antigen by Schwann cells in vitro. Cell Mol Life Sci 59, 2191–8.
Lilje, O. and Armati, P. J. (1997). The distribution and abundance of MHC and ICAM-1 on Schwann cells in vitro. J Neuroimmunol 77, 75–84.
Lilje, O. and Armati, P. J. (1999). Restimulation of resting autoreactive T cells by Schwann cells in vitro. Exp Mol Pathol 67, 164–74.
Lin, C., Numakura, C., Ikegami, al. (1999). Deletion and nonsense mutations of the connexin 32 gene associated with Charcot–Marie–Tooth disease. Tohoku J Exp Med 188, 239–44.
Lin, W., Sanchez, H. B., Deerinck, T., Morris, J. K., Ellisman, M. and Lee, K. F. (2000). Aberrant development of motor axons and neuromuscular synapses in erbB2-deficient mice. Proc Nat Acad Sci USA 97, 1299–304.
Linden, D. C., Jerian, S. M. and Letinsky, M. S. (1988). Neuromuscular junction development in the cutaneous pectoris muscle of Rana catesbeiana. Exp Neurol 99, 735–60.
Lindholm, D., Heumann, R., Meyer, M. and Thoenen, H. (1987). Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 330, 658–9.
Linington, C., Izumo, S., Suzuki, M., Uyemura, K., Meyermann, R. and Wekerle, H. (1984). A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J Immunol 133, 1946–50.
Linington, C., Bradl, M., Lassmann, H., Brunner, C. and Vass, K. (1988). Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130, 443–54.
Linington, C., Lassmann, H., Ozawa, K., Kosin, S. and Mongan, L. (1992). Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur J Immunol 22, 1813–17.
Linington, C., Berger, T., Perry, al. (1993). T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23, 1364–72.
Lisak, R. and Brown, M. J. (1987). Acquired demyelinating polyneuropathies. Semin Neurol 7, 40–8.
Lisak, R. and Bealmear, B. (1991). Antibodies to interleukin-1 inhibit cytokine-induced proliferation of neonatal rat Schwann cells in vitro. J Neuroimmunol 31, 123–32.
Lisak, R. and Bealmear, B. (1992). Differences in the capacity of gamma-interferons from different species to induce class I and II major histocompatibility complex antigens on neonatal rat Schwann cells in vitro. Pathobiology 60, 322–9.
Lisak, R. and Bealmear, B. (1994). Antibodies to interleukin-6 inhibit Schwann cell proliferation induced by unfractionated cytokines. J Neuroimmunol 50, 127–32.
Lisak, R. and Bealmear, B. (1995). Transforming growth factor-β (TGF-β) is co-mitogenic for Schwann cells (SC) with interleukin-α (IL-α). Neurology 45, A164–A165.
Lisak, R. and Bealmear, B. (1997). Upregulation of intercellular adhesion molecule-1 (ICAM-1) on rat Schwann cells in vitro: comparison of interferon-gamma, tumor necrosis factor-alpha and interleukin-1. J Peripher Nerv Syst 2, 233–43.
Lisak, R., Hirayama, M., Kuchmy, al. (1983). Cultured human and rat oligodendrocytes and rat Schwann cells do not have immune response gene associated antigen (Ia) on their surface. Brain Res 289, 285–92.
Lisak, R., Kuchmy, D., Rmati-Gulson, P. J., Brown, M. J. and Sumner, A. J. (1984). Serum-mediated Schwann cell cytotoxicity in the Guillain–Barré syndrome. Neurology 34, 1240–3.
Lisak, R., Sobue, G., Kuchmy, D., Burns, J. B. and Pleasure, D. E. (1985). Products of activated lymphocytes stimulate Schwann cell mitosis in vitro. Neurosci Lett 57, 105–11.
Lisak, R., Bealmear, B. and Ragheb, S. (1994). Interleukin-1 alpha, but not interleukin-1 beta, is a co-mitogen for neonatal rat Schwann cells in vitro and acts via interleukin-1 receptors. J Neuroimmunol 55, 171–7.
Lisak, R., Bealmear, B., Benjamins, J., Yu, C. and Skoff, R. (1996). Transforming growth factor-β (TGF-β) has different effects on proliferation of neonatal central (CNS) and peripheral (PNS) macroglia in vitro. Neurology 46, A190.
Lisak, R., Skundric, D., Bealmear, B. and Ragheb, S. (1997). The role of cytokines in Schwann cell damage, protection, and repair. J Infect Dis 176 (Suppl 2), S173–S179.
Lisak, R., Bealmear, B., Benjamins, J. and Skoff, A. (1998). Inflammatory cytokines inhibit upregulation of glycolipid expression by Schwann cells in vitro. Neurology 51, 1661–5.
Lisak, R., Bealmear, B., Benjamins, J. and Skoff, A. (1999). Tumor necrosis factor-α (TNF-α) upregulation of intracellular adhesion molecule-1 by Schwann cells is predominantly mediated by TNF receptor type I. Soc Neurosci Abstr 25, 294.
Lisak, R., Bealmear, B., Benjamins, J. A. and Skoff, A. M. (2001). Interferon-gamma, tumor necrosis factor-alpha, and transforming growth factor-beta inhibit cyclic AMP-induced Schwann cell differentiation. Glia 36, 354–63.
Lisak, R., Bealmear, B., Nedelkoska, L. and Benjamins, J. A. (2006). Secretory products of central nervous system glial cells induce Schwann cell proliferation and protect from cytokine-mediated death. J Neurosci Res 83, 1425–31.
Liu, H., Nakagawa, T., Kanematsu, T., Uchida, T. and Tsuji, S. (1999). Isolation of 10 differentially expressed cDNAs in differentiated Neuro2a ceFlls induced through controlled expression of the GD3 synthase gene. J Neurochem 72, 1781–90.
Lobsiger, C. S., Taylor, V. and Suter, U. (2002). The early life of a Schwann cell. Biol Chem 383, 245–53.
Loeb, J. A., Khurana, T. S., Robbins, J. T., Yee, A. G. and Fischbach, G. D. (1999). Expression patterns of transmembrane and released forms of neuregulin during spinal cord and neuromuscular synapse development. Development 126, 781–91.
Love, F. M. and Thompson, W. J. (1998). Schwann cells proliferate at rat neuromuscular junctions during development and regeneration. J Neurosci 18, 9376–85.
Love, F. M. and Thompson, W. J. (1999). Glial cells promote muscle reinnervation by responding to activity-dependent postsynaptic signals. J Neurosci 19, 10390–6.
Love, F. M., Son, Y. J. and Thompson, W. J. (2003). Activity alters muscle reinnervation and terminal sprouting by reducing the number of Schwann cell pathways that grow to link synaptic sites. J Neurobiol 54, 566–76.
Lubischer, J. L. and Bebinger, D. M. (1999). Regulation of terminal Schwann cell number at the adult neuromuscular junction. J Neurosci 19, RC46.
Lubischer, J. L. and Thompson, W. J. (1999). Neonatal partial denervation results in nodal but not terminal sprouting and a decrease in efficacy of remaining neuromuscular junctions in rat soleus muscle. J Neurosci 19, 8931–44.
Luitjen, J. A. F. M. and Faille-Kuyper, E. H. B. (1972). The occurrence of IgM and complement factors along myelin sheaths of peripheral nerves. An immunohistochemical study of the Guillain–Barré syndrome. J Neurol Sci 15, 219–24.
Lunn, M. P., Manji, H., Choudhary, P. P., Hughes, R. A. and Thomas, P. K. (1999). Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 66, 677–80.
Lupski, J. R., Oca-Luna, R. M., Slaugenhaupt, al. (1991). DNA duplication associated with Charcot–Marie–Tooth disease type 1A. Cell 66, 219–32.
Lustig, M., Zanazzi, G., Sakurai, al. (2001). Nr–CAM and neurofascin interactions regulate ankyrin G and sodium channel clustering at the node of Ranvier. Curr Biol 11, 1864–9.
Mackie, E. J. and Tucker, R. P. (1999). The tenascin-C knockout revisited. J Cell Sci 112 (Part 22), 3847–53.
Macleod, G. T., Dickens, P. A. and Bennett, M. R. (2001). Formation and function of synapses with respect to Schwann cells at the end of motor nerve terminal branches on mature amphibian (Bufo marinus) muscle. J Neurosci 21, 2380–92.
Madrid, R. E., Jaros, E., Cullen, M. J. and Bradley, W. G. (1975). Genetically determined defect of Schwann cell basement membrane in dystrophic mouse. Nature 257, 319–21.
Magda, P., Latov, N., Brannagan, T. H. III, Weimer, L. H., Chin, R. L. and Sander, H. W. (2003). Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 60, 1755–9.
Magyar, J. P., Martini, R., Ruelicke, al. (1996). Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 16, 5351–60.
Maier, M., Berger, P. and Suter, U. (2002). Understanding Schwann cell–neurone interactions: the key to Charcot–Marie–Tooth disease?J Anat 200, 357–66.
Mancardi, G. L., Cadoni, A., Zicca, al. (1988). HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. Neurology 38, 848–51.
Mandich, P., Mancardi, G. L., Varese, al. (1999). Congenital hypomyelination due to myelin protein zero Q215X mutation. Ann Neurol 45, 676–8.
Marchionni, M. A., Goodearl, A. D. J., Chen, M. al. (1993). Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362, 312–18.
Marcus, J. and Popko, B. (2002). Galactolipids are molecular determinants of myelin development and axo-glial organization. BBA Gen Subjects 1573, 406–13.
Maro, G. S., Vermeren, M., Voiculescu, al. (2004). Neural crest boundary cap cells constitute a source of neuronal and glial cells of the PNS. Nat Neurosci 7, 930–8.
Marques, W. Jr., Thomas, P. K., Sweeney, M. G., Carr, L. and Wood, N. W. (1998). Dejerine–Sottas neuropathy and PMP22 point mutations: a new base pair substitution and a possible ‘hot spot’ on Ser72. Ann Neurol 43, 680–3.
Martin, J. R. and Suzuki, S. (1987). Inflammatory sensory polyradiculopathy and reactivated peripheral nervous system infection in a genital herpes model. J Neurol Sci 79, 155–71.
Martin, S., Levine, A. K., Chen, Z. J., Ughrin, Y. and Levine, J. M. (2001). Deposition of the NG2 proteoglycan at nodes of Ranvier in the peripheral nervous system. J Neurosci 21, 8119–28.
Martini, R., Schachner, M. and Faissner, A. (1990). Enhanced expression of the extracellular matrix molecule J1/tenascin in the regenerating adult mouse sciatic nerve. J Neurocytol 19, 601–16.
Masaki, T., Matsumura, K., Saito, al. (2000). Expression of dystroglycan and laminin-2 in peripheral nerve under axonal degeneration and regeneration. Acta Neuropathol (Berl) 99, 289–95.
Masaki, T., Matsumura, K., Hirata, al. (2002). Expression of dystroglycan and the laminin-alpha 2 chain in the rat peripheral nerve during development. Exp Neurol 174, 109–17.
Massague, J., Andres, J., Attisano, al. (1992). TGF-beta receptors. Mol Reprod Dev 32, 99–104.
Massicotte, C. and Scherer, S. (2004). Neuropathies – Translating Causes into Treatments. Waxman, S. G. (Ed.), Elsevier, Philadelphia, pp. 401–14.
Mata, M., Siegel, G. J., Hieber, V., Beaty, M. W. and Fink, D. J. (1991). Differential distribution of (Na,K)-ATPase alpha isoform mRNAs in the peripheral nervous system. Brain Res 546, 47–54.
Mathey, E. K., Pollard, J. D. and Armati, P. J. (1999). TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies. J Neurol Sci 163, 47–52.
Matsumoto, K., Sawa, H., Sato, M., Orba, Y., Nagashima, K. and Ariga, H. (2002). Distribution of extracellular matrix tenascin-X in sciatic nerves. Acta Neuropathol (Berl) 104, 448–54.
Maurel, P. and Salzer, J. L. (2000). Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity. J Neurosci 20, 4635–45.
Maurer, M., Toyka, K. V. and Gold, R. (2002). Cellular immunity in inflammatory autoimmune neuropathies. Rev Neurol (Paris) 158, S7–S15.
McCarty, J. H., Lacy-Hulbert, A., Charest, A. et al. (2004). Selective ablation of {alpha}v integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death. Development.
McCombe, P. A., Clark, P., Frith, J. al. (1985). Alpha-1 antitrypsin phenotypes in demyelinating disease: an association between demyelinating disease and the allele PiM3. Ann Neurol 18, 514–16.
McCombe, P. A., McManis, P. G., Frith, J. A., Pollard, J. D. and McLeod, J. G. (1987a). Chronic inflammatory demyelinating polyradiculoneuropathy associated with pregnancy. Ann Neurol 21, 102–4.
McCombe, P. A., Pollard, J. D. and McLeod, J. G. (1987b). Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain 110 (Part 6), 1617–30.
McGrath, K. E., Koniski, A. D., Maltby, K. M., McGann, J. K. and Palis, J. (1999). Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4. Dev Biol 213, 442–56.
McKhann, G. M., Cornblath, D. R., Ho, al. (1991). Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet 338, 593–7.
McKhann, G. M., Cornblath, D., Griffin, J. al. (1999). Acute motor axonal neuropathy – a frequent cause of acute flaccid paralysis in China. Ann Neurol 33, 333–42.
McLennan, I. S. and Koishi, K. (2002). The transforming growth factor-betas: multifaceted regulators of the development and maintenance of skeletal muscles, motoneurons and Schwann cells. Int J Dev Biol 46, 559–67.
McLeod, J. G., Pollard, J. D., Macaskill, P., Mohamed, A., Spring, P. and Khurana, V. (1999). Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 46, 910–13.
McMahan, U. J. (1990). The agrin hypothesis. Cold Spring Harb Symp Quant Biol 55, 407–18.
Medzhitov, R. and Janeway, C. Jr. (2000). Innate immunity. N Engl J Med 343, 338–44.
Meier, C., Parmantier, E., Brennan, A., Mirsky, R. and Jessen, K. R. (1999). Developing Schwann cells acquire the ability to survive without axons by establishing an autocrine circuit involving insulin-like growth factor, neurotrophin-3, and platelet-derived growth factor-BB. J Neurosci 19, 3847–59.
Meier, C., Dermietzel, R., Davidson, K. G. V., Yasumura, T. and Rash, J. E. (2004). Connexin32-containing gap junctions in Schwann cells at the internodal zone of partial myelin compaction and in Schmidt–Lanterman incisures. J Neurosci 24, 3186–98.
Meintanis, S., Thomaidou, D., Jessen, K. R., Mirsky, R. and Matsas, R. (2001). The neuron-glia signal beta-neuregulin promotes Schwann cell motility via the MAPK pathway. Glia 34, 39–51.
Melcangi, R. C., Cavarretta, I. T. R., Ballabio, al. (2005). Peripheral nerves: a target for the action of neuroactive steroids. Brain Res Rev 48, 328–38.
Melendez-Vasquez, C., Redford, J., Choudhary, P. al. (1997). Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 73, 124–34.
Melendez-Vasquez, C. V., Rios, J. C., Zanazzi, G., Lambert, S., Bretscher, A. and Salzer, J. L. (2001). Nodes of Ranvier form in association with ezrin-radixin-moesin (ERM)-positive Schwann cell processes. Proc Nat Acad Sci USA 98, 1235–40.
Melendez-Vasquez, C. V., Einheber, S. and Salzer, J. L. (2004). Rho kinase regulates Schwann cell myelination and formation of associated axonal domains. J Neurosci 24, 3953–63.
Menichella, D. M., Arroyo, E. J., Awatramani, al. (2001). Protein zero is necessary fo